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It is now well established that mutant Wlcf mice show slow Wallerian
degeneration after nerve injury: The aim of the present thesis was to extend
knowledge and understanding of the protective effect of the Wlcf gene, and its
protein product on neuromuscular synapses. I used homozygous and heterozygous
Wlcf mice in studies that addressed three hypotheses:
1. Neuromuscular synaptic protection is more sensitive to Wlcf gene dose than
axon protection.
2. Age-dependent loss of neuromuscular synaptic protection is related to
changes in Wlds protein expression levels.
3. Synaptic degeneration in Wlcf mice can be further altered by other extrinsic
factors including nerve stump length and blocking neurotransmitter release.
Methods and Results
To test the first hypothesis, rates of synaptic degeneration were measured in
young (2 months old) heterozygous Wlcf mice crossbred with mice expressing
Yellow Fluorescent Protein (thyl. 2-YFP16 strain) in motor neurones. The results
suggest that synaptic degeneration in Wlcf mice is more sensitive to Wlcf gene-dose
dependence than axon degeneration
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The second hypothesis was addressed by comparing synaptic degeneration in
young (2 months old) heterozygous and homozygous Wlcf mice with, older (>6
months) homozygous Wlcf mice. The old mice were also crossbred with
thy.l-YFP16 mice but some data were also obtained using fluorescence
immunocychemistry for neurofilament and synaptic vesicle proteins. Confocal
microscopy and PDD's were used to obtain and analyse the data as before. The rate
and pattern of synaptic degeneration in old homozygous Wlcf mice were similar to
those in young heterozygous Wlf mice and wild-type mice. Immunofluorescence
measurements showed significant difference between Wlds protein levels in young
homozygotes and old homozygous Wlcf mice. Therefore, the loss of synaptic
protection in old Wlcf mice may also be explained by its sensitive gene-dose
dependence.
The third hypothesis was addressed first by comparing synaptic degeneration
protected by the length of nerve stump; specifically by comparing sciatic nerve
section and tibial nerve section. Second, the role of synaptic transmission was
examined by injecting botulinum toxin into the hind foot, sufficient to cause local
paralysis. Surprisingly, the result following sciatic/tibial cut did not show apparent
protection by increasing nerve stump length. The result from injection of botulinum
toxin into young Wlcf mice suggested that blocking transmitter release can delay
synaptic degeneration. However, in old Wlcf mice its effect disappeared. Therefore




Testing these hypotheses was facilitated by a novel geometric method was
facilitated by novel devised for representing different stages in the breakdown or
retraction of motor nerve endings. These representations (Polyhedral Degeneration
Diagrams, PDD) demonstrated clear differences in the rate and pattern of synaptic
degeneration following nerve injury in the different experimental groups of mice
examined.
Conclusions
Overall, the data I obtained provide evidence in support of a compartmental
neurodegeneration model which proposes that the survival or death of cell bodies,
motor axons and terminals of motor neurons are controlled by independent
regulatory mechanisms. The data further suggest that motor nerve terminals are an
especially vulnerable neurodegenerative compartment. Geometric PDD analysis of
synaptic degeneration may also find general utility and applicability to studies of
development or pathological models of neurodegenerative disease.
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The vertebrate nervous system is an extraordinarily complex communication
system that sends and receives information simultaneously in parallel pathways. The
nervous system has two distinct parts: the central nervous system and the peripheral
nervous system (the nerves outside the brain and spinal cord). Afferent and efferent
axons in the peripheral nervous system are gathered into nerve trunks, forming
defined peripheral nerves.
1.1 Neurons
The neurons that project axon into peripheral nerves are either sensory or motor.
Both sensory and motor neurons consist of a large cell body (or soma) with
branching dendrites (signal receivers) and a projection called an axon, which
conducts the nerve signal (Fig 1.1). At the other end of the axon, the axon terminals
transmit an electro-chemical signal across a synapse (the gap between the axon
terminal and the receiving cell).
The cell body is the bulbous end of a neuron, containing the nucleus. The cell
nucleus is a key feature of the cell body. It is the source of most of the RNA that is
produced in neurons and most proteins are produced from mRNAs that do not travel
far from the nucleus. Other RNA comes from cytoplasm, such as tRNA.
An axon is a long, slender projection of a nerve cell that conducts electrical
impulses away from the neuron's cell body.Axons are in effect the primary
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transmission lines of the nervous system, and are bundled together to form nerves.
Individual axons are microscopic in diameter - typically about one micrometre
across (1pm) - but may extend to macroscopic (>lmm) lengths. The longest axons in
the human body, for example, are those of the sciatic nerve, which run from the base
of the spine to the big toe of each foot. These single-cell fibers of the sciatic nerve
may extend a meter or even longer.
In vertebrates, the axons of many neurons are sheathed in myelin, which is
formed by either of two types of glial cells: Schwann cells ensheathing peripheral
neurons and oligodendrocytes insulating neurons of the central nervous system.
Along myelinated nerve fibers, gaps in the sheath known as nodes of Ranvier occur
at evenly-spaced intervals, enabling a particularly rapid mode of electrical impulse
propagation called saltation.
This myelin sheath resembles insulation, such as that around an electrical wire.
Nerve impulses travel much faster in nerves with a myelin sheath than in those
without one. Velocity of impulse is a factor of axon diameter, myelin thickness and
internodal length. If the myelin sheath of a nerve is damaged, nerve conduction is
dramatically reduced (Tsao et al., 1994; Court et al., 2004).
Dendrites are the branched projections of a neuron that act to conduct the
electrical stimulation received from other neural cells to the cell body of the neuron
from which the dendrites project. Electrical stimulation is transmitted by upstream
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neurons onto dendrites, via synapses which are located at various points throughout
the dendritic arbor. Dendrites play a critical role in integrating these synaptic inputs
and in determining the extent to which subsequent action potentials are produced by
the neuron.
Synapses
The "Neuron doctrine" was first proposed by Santiago Ramon Y Cajal and his
colleagues in late of 19th century. He proposed that the connections between the
neurons are made at a specialized site. These sites were subsequently named
"synapses" by Charles Sherrington (Sherrington, 1897; 1906). Synapses are
symmetric and asymmetrical communication junctions formed between two neurons.
The term 'synapse' has since been extended to include communication between a
neuron and non-neuronal target cell; for instance, at the neuromuscular junction
(NMJ), between a motor neuron and a muscle cell.
Synapses play a critical role in neural function by transmitting signals from one
neuron to another or muscle fibres at NMJs. There are in fact two ways of synaptic
transmission occurs between neurons: electrical and chemical. At electrical synapses,
the ion channels bridge the pre and post-synaptic membrane and information may be
carried symmetrically between the two connected cells directly. The other, more
common form of synapses makes use of chemical intermediaries. At chemical
synapses, the two neurons are separated by a 30nm gap, the synaptic cleft. Signals
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are transmitted asymmetrically, when the presynaptic neuron releases a chemical
neurotransmitter by exocytosis from synaptic vesicles into the synaptic cleft. These
molecules are detected by the postsynaptic neuron through activation of specific
molecular receptors exactly opposite the release site of the presynaptic terminals. At
NMJ the receptors are acetylcholine receptors.
1.2 Neuromuscular Junctions
The vertebrate neuromuscular junction (NMJ) is arguably the best system for
studying the formation, maturation, elimination and regeneration of synaptic
connections. The NMJ is constructed from three main cellular components—nerve
terminal, muscle fibre, and terminal (presynaptic) Schwann cell (Sanes and
Lichtman., 1999). With the advent of electron microscopy, a clear picture of NMJ
strucuture became available, showing the synaptic cleft that separates the motor
nerve terminal and skeletal muscle fibre, numerous synaptic vesicles and
mitochodria in the presynaptic terminal, the electron dense postsynaptic membranes
thrown into numerous postsynaptic folds and a layer of extracellular matrix lining
the synaptic cleft (Figure 1.2). Many studies have been carried out on at the NMJs
since these observation were made.
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Figure 1.2
Diagram showing the cellular organization of the NMJ
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Skeletal muscle fiber receptors
(Image from Purves et al., Life: the Science of Biology, 4th Edition,
by Sinauer Associates and WH Freeman)
Dale et al (1939) were first to describe chemical neurotransmitter release in
the synapses of the vertebrate NMJs. After that, a series of experiments on
electrophysiology of chemical synaptic transmission at NMJs were carried out by
Fatt and Katz (Fatt and Katz, 1951; Fatt and Katz, 1952). They suggested that the
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change in permeability of the nerve terminal membrane to Ca ions triggers
synaptic transmission, exocytosis of synaptic vesicles, releasing quantal packets of
acetylcholine. Subsequent analysis established that neurotransmitter is released in
packets of 5000-molecule "quanta" and that this occurs randomly and spontaneously
at resting synapses. Excitation of the nerve terminal, for example by a depolarizing
action potential, leads to influx of Ca2+ ions, leading to synchronous synaptic release
of many tens or hundreds of synaptic vesicles (Fatt and Katz, 1952; del Castillo
and Katz, 1954; Katz and Miledi, 1969; Wood and Slater, 1997). Within the
presynaptic nerve terminal, synaptic vesicles containing neurotransmitter
acetylcholine are clustered near to the presynaptic membrane (Palade and Palay,
1954; Robertson, 1956; Whittaker et al., 1964). Synaptic vesicles often aggregate
around the 'active zones' and neurotransmitters are secreted by exocytosis of
synaptic vesicles at these sites which produces postsynaptic activation. Using
electron microscope tomography in the frog's NMJ, Harlow et al (2001) suggested
that active zone material facilitates vesicle docking and localizes calcium channels to
release sites.
Many proteins play crucial roles in regulating and driving the synaptic vesicle
cycle, namely docking, fusion, endocytosis, and recycling (Betz and Angleson 1998).
P-type calcium channels are distributed throughout the presynaptic membrane and
are important for vesicle exocytosis as they allow Ca2+ to enter. Voltage-gated
potassium and calcium channels are also found to localize within active zones of
presynaptic membrane to help increase the release of neurotransmitter (Uchitel et al.,
1992, Robitaille et al., 1993.; Day et al., 1997). One study suggests that the
presynaptic membrane protein plays an important role in vesicle docking at the
presynaptic membrane (Pevsner et al., 1994). Integrins also help facilitate
neurotransmitter secretion. They attach the nerve terminal, which assist
neurotransmitter release sites anchored firmly on the postsynaptic receptors (Chen
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and Grinnell, 1995).
The membrane opposite presynaptic nerve terminals is corrugated into
junctional folds. At the rat neuromuscular junction, the postsynaptic folds appear to
enhance the safety factor for neuromuscular transmission (Wood and Slater, 1997).
Moreover, the presynaptic active zones (transmitter release sites) in the presynaptic
terminal position are positioned directly opposite the opening of junctional folds in
the postysynaptic membrane (Patton et al., 2001). The majority of nicotinic
acetylcholine receptors (AChRs) are located at peaks of the junctional folds of the
postsynaptic membrane (Salpeter and Loring, 1985). Voltage-gated sodium channels
are located in the troughs of the folds (Flucher and Daniels, 1989). The muscle
action potential is triggered by the local endplate potential produced by activating
the AChRs, which then leads to voltage-dependent activation of these sodium
channels.
Many cytoskeletal elements are thought to play an important role in generating
and maintaining the postsynaptic folds (Sanes and Lichtman, 1999). For example, at
l
the top of junctional folds, a-dystrobrevin-1, a member of the dystrophin family of
proteins (Bewick et al ., 1992; Peters et al., 1998), rapsyn (Wang et al., 1999), and
utrophin (Gramolini et al., 2000) are associated with the AChRs. Other proteins such
as a-dystrobrevin-2 (Peters et al., 1998) ankyrin (Zhou et al., 1998) and P-spectrin
(Wood and Slater., 1998) are found in the depths of the junctional folds.
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Terminal Schwann cells are a non-myelinating population around the nerve
terminals. They cover the terminal and isolate it from the surrounding environment.
These Schwann cells are distinct from those that form myelin sheaths (Waxman,
1997) around the axon. Although, non-myelinating Schwann cells and
myelin-forming Schwann cells come from the same progenitor, they express
different genes during development. For instance, myelin basic protein Po and
myelin associated glycoprotein (MAG) are expressed higher in the axonal Schwann
cells than S-100 and N-CAM, in contrast to S-100 and N-CAM which are expressed
higher in the terminal Schwann cells than protein Po and MAG (Mirsky and Jessen,
1996). Myelin-forming Schwann cells help increase conduction velocity, along the
axon, moreover the cells may supply trophic factors that support the axons. On the
other hand, terminal Schwann cells play an active role in the formation, maintenance
and repair of developing NMJs (Meier and Wallace, 1998). For example, at
developing neuromuscular junctions, Schwann cells appear to support motor neurons
through the release of neurotrophic factors, such as, CNTF, GDNF, BDNF, and NT-3.
Furthermore, during denervation, terminal Schwann cells guide sprouting or
regenerating axons back to the original place of innervation (Reynolds and Woolf,
1992; Son and Thompson 1995).
Schwann cells express muscarinic and purinergic receptors, which are related to
the release of acetylcholine and ATP (Robitaille, 1995; Robitaille et al., 1997).
Synaptic activity leads to a rise in intracellular calcium, (Jahromi et al., 1992), which
it
in turn may alter in gene expression. For example, the gene for glial fibrillary acidic
protein, which plays a role in the formation of the terminal Schwann cell sprout, is
stimulated by a blockage in synaptic activity (Love and Thompson, 1998).
1.3 Synaptic plasticity, development, degeneration
The nervous system has been described as a dynamic and flexible network that
responds to change in the surrounding environment. Information in this entire
dynamic neuronal system is mediated by neural activity, and this activity brings
about changes in the patterning and strengths of neuronal connections.
Activity-dependent plasticity of synaptic connection is important both in the CNS
and the PNS, for example, at the synapses in the visual cortex as well as at
neuromuscular synapses during development (Thompson et al., 1977; Ridge and
Betz, 1984; Walsh and Lichtman, 2003; Kasthuri and Lichtman, 2003; Buffelli et al.,
2003). However, arguably the most dramatic changes in motor nerve terminal form
and function occur after an axon is injured, separating the synaptic terminals from
their motor neuron cell bodies, an event that may also occur in neurodegenerative
diseases, such as motor neuron diseases (MND; Schaefer et al., 2005; Fischer et al.,
2004; Pun et al., 2006).
Withdrawal of motor terminals (synapse elimination) is a type of synaptic
rearrangement and plasticity which has been most heavily researched. Early studies
showed that in the neonatal mammals, each immature muscle fibre is supplied by
12
two or more motor axons which converge on to a single end-plate, which thus
receives multiple "polyneuronal" synaptic inputs. At two weeks after birth all muscle
fibres are innervated by only a single motor axon (Redfen, 1970; Brown et al., 1976).
Similar changes in the innervation pattern are also found following axonal
regeneration in the adult muscle after nerve injury (McArdle, 1975;
Ribchester, 1988; Costanzo et al., 1999).
Synapse elimination has also been studied in regions of the CNS; for example,
the cerebellum (Lohof et al., 1996) the autonomic ganglia (Lichtman, 1977) and the
visual system (Hubel et al., 1977).
1.4 Wallerian degeneration
In 1850, Augustus Waller first described the orthograde degeneration of axons
after nerve injury, and what we now called this process "Wallerian degeneration".
Waller cut the glosspharyngeal and hypoglossal nerves of the frogs, then observed
the distal nerves that were separated from their cell axons becoming discontinuous,
and fragmented after parting from the cell bodies. He also suggested that "trophic
influence" plays a role in maintaining the distal extremities of a neuron, for example,
that distal axons degenerate after injury because the trophic substances can not be
supplied.
Due to the limitation of the staining techniques available in that period, Waller's
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findings were not accepted until in the late 19th century (1878). Ranvier, among
others, extended studies of Wallerian degeneration in axons. He observed the
fragmentation of the axon following nerve section and the later invasion of
phagocytotic leucocytes later. He first described Schwann cell division during this
process which was later confirmed by the findings of Biingner (1891). He was also
the first person to observe structures he named as "bands of Btingner". Band of
Btingner, also called the Schwann cell column, are formed by Schwann cells, which
lose contact with axons, proliferate, then form a cell strand within the basal lamina
tube. In 1928, these studies were confirmed by Ramon y Cajal who used silver
staining techniques to demonstrate the degeneration of the distal nerve stump after
axotomy.
1.4.1 Wallerian degeneration in the Axon
After a nerve has been transected, the lesioned axon begins to fragment; the
myelin sheath retracts from the nodes of Ranvier to form the large spaces called
'digestive chambers' or ellipsoids', and the nerves are separated in these
compartments (Allt, 1976). The axon fragments then proceed to a complete
degradation. While the distal stump continues to degrade, the debris of the axons is
cleaned by the phagocytosing Schwann cells and invading macrophages. At the same
time, Schwann cells transiently proliferate. Abercrombie and Johnson (1946)
demonstrated that in the rabbit sciatic nerve, the number of Schwann cells increased
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13-fold by 25 days post lesion. The proliferating Schwann cells form a cell strand
called Schwann cell column or band of Bungner (Biingner, 1891) within the basal
lamina tube. The regenerating axons from the proximal stump of the lesion are
guided by these bands back to the distal nerve segment. During this process, many
different growth and adhesive factors such as NGF (Heumann et al., 1987),
N-CAM( Nieke and Schachner, 1985) and cytokines (including members of the
interleukin (IL-x) family (for review see Fu and Gordon, 1997), all of which are
secreted from the Schwann cells, appear to play important roles in assisting axonal
regeneration.
During axonal fragmentation and degradation, Wallerian degeneration is
naturally accompanied by failure of conduction of action potentials in the nerve
(Mastalgia et al., 1976; Nicholls et al., 1992). The lag period after axotomy in the
axons varies in the different species. In mice, for example, the sciatic nerve fails to
conduct action potentials for 1 — 2 days following axotomy. This is in contrast to
the effect of axotomy in frogs, where the action potential can still be recorded up to 7
days post sciatic nerve axotomy (Levenson and Rosenbluth, 1990; Chaudry, Glass
and Griffin, 1992). Remarkably, in the giant squid, crayfish and fish, the isolated
axons are preserved even for months (Sheller and Bittner, 1992; Tanner et al., 1995;
Raabe et al., 1996).
The fragmentation of endoplasmic reticulum and distintegration of
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neurofilaments and microtubules in the 24-72 hours following nerve axotomy are the
early axonal changes observed by electron microscopy (Vial, 1958; Honjin et al.,
1959; Ballin and Thomas, 1969; Donat and Wisniewski, 1973; Schlaeper and Hasler,
1979a). A subsequent marker of degeneration is the swelling and dissolution of
axonal mitochondria. There is evidence that axonal degradation during Wallerian
degeneration is a calcium-mediated event when the intracellular calcium
concentration rises above a threshold concentration of 0.2mM, neurofilament
degradation occurs (Glass et al., 1994). Evidence in support of this hypothesis is
neurofilament can be maintained intact when incubated in calcium-free media
(Schlaepfer and Hasler, 1979b).
The velocity of Wallerian degeneration is dependent on temperature, the age of
the animal, and the myelination and caliber of the nerve. Low temperatures slow the
rate of Wallerian degeneration in mammalian, invertebrate and lower vertebrate
axons (Usherwood et al., 1968; Wang, 1985; Bittner, 1988; Sea et al., 1995; Tsao et
al., 1999). The rate of Wallerian degeneration in the optic nerve of cats is slower in
the older animals, (Cook et al., 1974). In a study with teased fibres of transected
phrenic nerves, the amount of Wallerian degeneration was shown to be least in the
thickest fibre at 24 hours (Lubinska, 1977). Thus, unmyelinated axons degenerate
first, then the smallest myelinated nerve fibres, and the largest myelinated fibres are
the last to degenerate (Weddel and Glees, 1941; Friede and Martinez, 1970). Recent
research suggests that mice which lack inducible nitric oxide (iNOS) also show slow
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Wallerian degeneration in myelinated axons (Levy et al., 2001), suggesting a role for
oxidative enzymes in this process.
In contrast to the rapid degeneration of the distal portion of an axotomised
neuron, the proximal portion does not degenerate, at least in adults. There are
however some distinct markers of change, in the cell body and its nucleus, the cell
body swells, the Nissl substance becomes dispersed, and the nucleus translocates, the
nucleus moves from the center of the cell soma to an eccentric location. In some
proximal axons motor neuron cell bodies degenerate after avulsion of the spinal
roots, a procedure which leaves a very short proximal nerve stump (see Adalbert et
al., 2006).
1.4.2 Wallerian degeneration in synaptic terminals
The progression of Wallerian degeneration at the NMJ has been
well-documented, in frogs, rats and mice, by such people as Birks, Katz and Miledi
(1960), Miledi & Slater (1968 and 1970), Manolov (1974) and Winlow and
Usherwood (1975). The degeneration of nerve terminals post axotomy occurs before
the degeneration of the axons. In some animals, like rat and frog, initial degenerative
changes in the nerve terminals occur within 3-8hours; (Manolov, 1974; Miledi and
Slater, 1970). These changes include the swelling and destruction of mitochondria;
reduction in the number, and clustering of synaptic vesicles, and subsequently
invasion of terminal Schwann cells into the synaptic cleft. More degenerative
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changes occur with passing time, like nerve terminals becoming completely
fragmented and the terminal Schwann cell engulfing the synaptic terminal.
The numbers and localization of the synaptic vesicle population in motor nerve
terminals changes following axotomy, as described by Manolov (1974) and Winlow
and Usherwood (1975). From 6hrs to 20 hours the numbers of synaptic vesicles
decrease dramatically (Manolov, 1974). Manolov and Winlow and Usherwood
described a small reduction in synaptic vesicle numbers occuring 3 hours after nerve
section. However, at 20 hours post-axotomy, the majority of nerve terminal profiles
had no vesicles left. Manolov found greatly increased neurofilaments, following the
reduction in number of synaptic vesicles and degeneration of mitochondria in many
nerve terminals which survive for more than 20 hours post axotomy.
Mitochondria are used as an important marker for synaptic terminal
degeneration. Miledi and Slater (1970) studied the changes in normal NMJs and
axotomised NMJs. In normal nerve endings, diameter of mitochondria is 0.1 -0.2 jam,
whereas in endplates undergoing degeneration, mitochondria become swollen and
have large circular profiles with diameters as large as 0.7/am. The cristae in the
mitochondria often appear "disorganized and broken up into small vesicular
fragments" (Miledi and Slater, 1970). In Manolov's (1974) experiments, the same
phenomenon was reported as the occurrence of 'dense bodies'.
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1.5 Synapse Elimination at the Neruomuscular
junction
In rodents, neuromuscular synaptogenesis occurs after myoblast fusion during
development, when each motor neuron establishes synapses on different muscle
fibres randomly (Bennett and Pettigrew, 1974, Jennings, 1994). By the end of this
period each skeletal muscle fibre is supplied by more than one motor axon. Synapse
elimination then begins to refine these connections during the first two postnatal
weeks (Redfen, 1970; Brown et al., 1976; Betz et ah, 1979). Studies have shown that
synapse elimination also occurs in other species' nervous systems, such as humans
and kittens (Huttenlocher 1982 et ah, Bagust et ah, 1973).
In 1976, Brown and colleagues studied the elimination of polyneuronal
innervation in the soleus muscle of new-born rats. It was found that during the
poly-innervation to mono-innervation transition period, there was no significant
reduction in the number of motor neurons innervating the soleus muscle. Therefore
they concluded that the disappearance of supernumerary inputs reflects a decrease in
the number of synapses made by each motor neuron (Brown et ah, 1976). The
ultrastructure of nerve terminals on neonatal muscle fibres was studied using
electron microscopy. This provided evidence that synapse elimination involved
retraction of motor nerve terminals from the endplates rather than the Wallerian
degeneration process that occurs after nerve injury. No signs of degenerative
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processes were found in any nerve terminal during synapse elimination, either in rats,
or in rabbits' experiments (Komeliussen et al., 1976; Bixby, 1981). Moreover Bixby
described how the nerve terminals and axons are retracted from the endplates to form
retraction bulbs.
However, one study suggested that the supernumerary terminals are removed by
degenerative mechanisms. Rosenthal and Taraskevich (1977) described that signs of
abnormal ultrastructure were observed in neonate end-plates during the period of
synapse elimination. Some terminals had a high condensation of synaptic vesicles as
well as Schwann cell encroachment into the synaptic cleft, and it was evident that the
large areas of postsynaptic membrane opposed only with Schwann cell. All of these
characteristics are similar to Wallerian degeneration of motor nerve terminals in the
denervated adult mice. However, there have been no published reports to confirm
their findings, so they may be incorrect, more research is needed before ruling out
this mechanism entirely.
The majority of evidence from other studies support that the supernumerary
inputs are removed by withdrawal process rather than degeneration. Although
previously focused on reinnervated NMJs, in recent years, Lichtman and his
colleagues have studied the mechanism of synaptic elimination at the developing
neuromuscular junction using a time-lapse imaging technique. In 2001, they used
transgenic mice that express fluorescent proteins in subsets of axons. The results
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suggested that branch elimination within a same motor unit appears to be distributed
randomly and asynchronously, and that the local competitive environment plays a
critical role in deciding branch loss and maintaintenance (Keller-Peck et al., 2001).
Subsequently, Lichtman and his colleagues used two transgenic mouse lines
designated YFPH and CFP which expressed yellow and cyan fluorescent proteins in
different motor axons and developed the time-lapse imaging technique further. They
suggested that competition between two axons from two different motor neurons
innervating the same synaptic area leads to one axon's retraction accompanied by
another axon's expansion (Walsh et al., 2003). In the same year, they used the same
technique to further investigate the nature of the neuronal competitors. Their
findings suggest that motor neurons form a hierarchy indicated by the endplates they
acquire and exclude from other motor units (Kasthuri et al., 2003).
1.6 The Wlcf phenotype
The Witf mice mouse phenotype was first discovered by H Lunn, M.C. Brown,
and V.H. Perry, by accident while investigating the role of recruited myelomonocytic
cells in Wallerian degeneration of peripheral nerve (Lunn et al., 1989). Mice were
originally supplied by Harlan-Olac to Oxford and many other universities and
research institutes in the UK and abroad as C57/B16 mice. However, these mice bear
the spontaneous mutation that slows axonal degeneration, which neither C57/B16J
nor C57/B16 mice (nor any other mouse line studies to date) show. The initial studies
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of the mutant mice referred to them as "Ola" mice. The formal "Wlcf" was adopted
after the chromosomal location of the mutant gene was established (Lyon et a., 1993).
Evidently, at some point in the lineage of the Harlan-Olac C57/B16 mice there was a
spontaneous mutation that was conserved. The mutant mice breed easily and don't
show any discernible, neurological phenotype compared with wild type mice. The
most distinguishing characteristic of these mice is that Wallerian degeneration is
significantly delayed after axotomy or nerve injury. The distal axotomised section
and their nerve terminals are preserved completely for as long as 3 weeks in some
cases. Of note, the isolated distal axons are still be able to conduct action potentials,
and the motor neuromuscular nerve terminals continue to release neurotransmitter
and recycle synaptic vesicle for at least 3 days, and in some cases, up to 2 weeks
after axotomy (Tsao et al., 1994; Ribchester et al., 1995). Wallerian degeneration is
delayed in both sensory and motor axons in these mutant mice after peripheral nerve
injury. Moreover the mutation also delays axonal and synaptic degeneration in the
central nervous system (Perry et al., 1990a; Ludwin and Bisby, 1992; Gillingwater et
al., 2006a).
1.7 The Wlcf genotype
Perry et al (1990b) showed that the mutant gene in Wlcf is autosomal dominant.
The mutant gene in Wlcf mice was then mapped to the distal end of chromosome 4
(Lyon et al., 1993), and was subsequently identified within the candidate region to be
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an 85-kb tandem triplication; this is a mutant unique to the Wlcf mice (Coleman et al.,
1998). From recent studies exons of three genes were found within the triplicated 85
kb domain (Conforti et al., 2000). Expression of two genes spanning the proximal
and distal boundaries of the repeat unit can be found in the nervous system namely
the N-terminal 70 amino acids of ubiquitin fusion degradation protein 2 (Ufd2) and
the C-terminal 302 amino acids of D4Colele were identified. In the Wlcf mutant,
these two transcripts form an open reading frame for a 43 kDa chimeric protein.
However, the third exon in the repeat unit, Rbp7 (a novel member of the cellular
retinoid -binding protein family), does not express in the nervous system (Conforti
et al., 2000; Figure 1.3). Naturally, attention was focused on the chimeric gene as the
best candidate for conferring the slow Wallerian phenotype. Ufd2 has now been
demonstrated to be homologous to the human ubiqutination factor E4b (Ube4b)
(Mack et al., 2001). Similarly, the novel sequence D4Colele is now shown to
incorporate a complete sequence that encodes Nicotinamide mononucleotide
adenylyl transferase-1 (Nmnat-1). This enzyme is a nuclear protein and is
responsible for NAD synthesis (Emanueli et al., 2001). In addition, the chimeric
gene (N70Ube4b/Nmant) includes an N-terminal sequence coding for an additional
18 amino acids in Wlcf mice. The gene sequence for this peptide is not normally
found in wild-type Nmnat. Mack et al (2001) made several lines of transgenic mice
expressing N70Ube4b/Nmnat. The amount and rate of Wallerian degeneration after
axotomy was shown to be gene dose—dependence (Figure 1.4). For instance, the
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data demonstrated that axonal preservation in the heterozygous transgenic mouse
line 4836Tg/+ was similar to that in the mutant Wlct mice after the same duration of
axotomy, In contrast, heterozygous Tg 4830 mice exhibited only half the axonal
preservation compared to Wlct homozygotes.
It is important to point out at this stage that homozygous Wlct mice therefore
express four copies of the chimeric Wlct gene, in addition to normal expression
levels of Nmnat and Ube4b that make up the mutant gene. Heterozygous Wlct mice
have only two copies of the chimeric gene. Evidence suggests that Wlds protein in
expressed in proportion to the number of copies of the Wlct gene (Mack et al., 2001;
see figure 1.3). Thus comparing phenotypes in homozygous and heterozygous Wlct
mice gives a simple and effective way of testing for the effect of the Wlct
"gene-dose".
A recent genome-wide analysis protein expression profile of Wlct mutant in
both the mouse cerebellum and human cell cultures revealed that the
Nmnat-1/Ube4b chimeric protein regulates a wide range of proteins both positively
and negatively. Two prominent candidates were examined in further detail: pituitary
tumor transforming gene-l(pttg-l) and erythroid differentiation regulator-1
(edrl/-EST). mRNA expression of pttg-1 was dramatically reduced by 10 fold,
whilst edrl/-EST mRNA expression was increased by 5 fold. Interestingly, Nmnat-1
and Ube-4b have different roles in regulating the expression of pttg-1 and edrl/-EST
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(Gillingwater et al 2006b). These data strongly suggest that the Wlcf gene product
has a gobal control over a large pool of genes in mediating a neuroprotective effect
in Wlcf mutant mice, with a similar pattern also observed in human cell lines.
1.8 Mechanism of Neurodegeneration in Wlcf mice
Work on finding the cellular mechanism of the slow Wallerian degeneration in
the WZcf mice has long preceded the understanding of its molecular nature. In 1989,
Lunn et al. first postulated that the failure to recruit systemic macrophages to the
distal stump cells in C57BL/6/01a mice (the line subsequently renamed C57B16/WZ<f
mice) accounts for the slow rate of degeneration. However, in subsequent
experiments, they refuted this hypothesis by performing transplant experiments
(Perry et al., 1990c) which suggested that slow degeneration was caused by an
intrinsic property of the peripheral nerve. This finding was confirmed by Glass et al
(1993), who found that axonal degeneration in Wlcf mice was host-dependent after
axotomy. In their experiments, Wlcf axons which regenerated through grafts of
peripheral nerve sheaths which containing wild-type Schwann cells degenerated
slowly after the regenerated axons were removed, whereas, wild-type axons
containing Wlcf Schwann cells still degenerated rapidly after removal. Moreover,
Wlcf axons still degenerated slowly after nerve injury when the perineurial sheath
was injected with the lysophosphatidyl choline to produce a demyelinating lesion
(Hall, 1993). Thus, Schwann cells don't appear to show any critical effect on the
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slow degeneration of axons in Wlcf mice. This conclusion is supported by studies of
the WZ^phenotype in vitro. However, Deckwerth & Johnson (1994) showed that
when NGF was deprived, in cultures of Wlcf neurons, the axons persisted, but the
cell bodies underwent apoptosis.
Recent researches have been focused on the molecular mechanism of axon
protection by the Wlcf gene. In particular, efforts have been made to reveal the
function of the N70Ube4b and NMNAT genes involved in protection of axons and
nerve terminals in the axotomised Wlcf mice. Hershko, Liechnover and colleagues in
1980 first described the role of ubiquitin (a small, 76 amino acid polypeptide) as a
macromolecular tag, which marks proteins destined for degradation to 26s
proteosomes (Glickman and Ciechnover, 2002). In 1984 Thomas and Wyman first
suggested that the ubiqutination pathway might be involved in the regulation of
synaptic connectivity. They described that abnormal synaptic connection between the
giant and the tergotrochanter motor neurons resulted from the disruption of the
ubiquitin gene in Drosophila. Therefore, one hypothesis is that the partial
incorporation of E4 ubiqutination factor Ube4b in the Wlcf may block degeneration
by interfering with protein ubiqutination (Gillingwater and Ribchester, 2001; Mack
et al., 2001; Coleman and Perry, 2002).
Nicotinamide mononucleotide adenylyl-transferased (Nmnat) is a whole
sequence in the Wld gene. This enzyme plays various roles in cells. It is involved in
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the NAD biosynthesis, electron-transport in the respiratory chain within
mitochondria, and regulates DNA repair and transcription. Therefore, Nmnat could
play a critical role in neuroprotective effects observed in the Wlcf mice. Araki et al
(2004) reported that increased nuclear NAD biosynthesis by SIRT1 activation could
prevent axonal degeneration. The SIRT1 is located in the nucleus and involved in the
regulation of transcription factors such as P53 and chromatin remodeling factors.
Thus Araki et al concluded that axonal protection in Wlct was mediated by increased
Nmnat activity. However, their study was partially refuted by Wang et al (2005), and
Conforti et al (2007) who showed that transgenic mice overexpressing Nmnat alone
did not show significant protection as in the Wlcf mice. However, other studies
suggested that overexpression of Nmnat in Drosophila does protect axons and
synapses from degeneration (Hoopfer et al., 2006; MacDonald et al., 2006). Taken
together, all these studies suggest that the role of Nmnat has yet to be fully resolved.
Slow Wallerian degeneration is not the only effect of the Wlct mutant gene.
Although Wlcf mice show no obvious difference from the wild-type in appearance
and behaviour, other phenotypic features can also be found in the operated and
unoperated Wlcf mice. In unoperated Wlcf mice, the soleus muscles have more fibres,
fewer resident macrophages and lower levels of acetylcholine sensitivity than in
wild-type mice. Moreover, the level of serum creatine kinase is lower in C57BL/01a
mice compared to wild type (Brown et al., 1991). As most creatine kinase (CK) is
expressed in muscles, a rise in the amount of CK released into the blood indicates
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that muscle damage has started to occur. In operated Wlcf mice, increases of both
acetylcholine and CK occurred more slowly compared to wild-type mice. This
slowly-occurring increase of supersensitivity to ACh is perhaps not surprising since
this could be partially induced by a release of products from nerve degeneration in
Wlcf mice (Brown et al., 1991). Schwann cells show different characteristics in wild
type and mutant Wlcf mice in response to axotomy. In vivo, the resident Schwann
cells play an important role in the maintenance of cell types producing maintenance
factors which are absorbed by the axon. In peripheral nerves, ciliary neurotrophic
factor (CNTF) is expressed in a subset of Schwann cells, when Wallerian
degeneration occurs, synthesis of CNTF is decreased. Subang et al (1997) showed
that both mRNA and protein levels of CNTF decreased quickly and synchronously
and quickly in the axotomised wild type mice. Nevertheless, in Wlcf mice following
axotomy, CNTF remains normal both as mRNA and protein level for up to 4 days.
During Wallerian degeneration, the levels of the CNTF protein decrease at a slower
pace than the levels of CNTF mRNA in Wlcf mice. This suggests that the stability of
CNTF protein in the axotomised Wlcf mice, may contribute to the protection of
axons. However, it is also plausible that the delayed response of Schwann cells to
nerve injury in Wlcf is due to the absence of signal from degenerating axons in Wlcf
mice (since the axons don't degenerate).
Chemotactic factors produced by the injured nerve, or the loss of inhibitory
factor produced by the intact axon could influence macrophage recruitment after
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axotomy (Perry et al., 1990c). In particular, one of the chemotactic factors, monocyte
chemoattractant protein-1 (JE) fails to be produced in the axotomised Wlct mice
(Carroll and Frohnert, 1998). Another chemoattractant, granulocyte macrophage
colony stimulating factor (GM-CSF), is deficient in Wlct mice following axotomy.
Furthermore, it is likely that distal axons produce an inhibitory factor to prevent
macrophage recruitment in axotomised Wlct (Perry et al., 1987; 1990c, Brown et al
1991; 1991a), this does not occur in the axotomised wild-type mice (Ludwin and
Bisby, 1992, Gillingwater and Ribchester, 2001).
1.9 Synapse Degeneration in Young Wlcf Mice
Motor nerve terminals in young Wlct mice appear undergo a different process
from the classic Wallerian degeneration. Wlct NMJs still retain the ability to release
neurotransmitter and recycle synaptic vesicle membrane for at least 3 days, and in
some cases for 2 weeks, following nerve axotomy (Ribchester et al., 1995).
At wild-type denervated NMJs, synaptic terminals degenerate synchronously.
However, the morphology of terminal degeneration in axotomised Wlct mice is
distinct. Using vital dye labeling immunocyto-chemistry and electrophysiology, a
piecemeal form or withdrawal of axotomised Wlct nerve terminals and retraction of
axons have been suggested by several studies indicated by the progressive,
asynchronous loss of synaptic contract at individual endplate (Mattison et al., 1996;
Parson et al., 1998; Ribchester et al., 1999). These studies suggest that axotomised
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nerve terminals are gradually removed from the endplates, until they retract back to
the distal end of the axon. The ends of the axons appear to the swollen "retraction
bulbs", which are detached from the endplates (Mattison, 1999). Physiological
experiments also demonstrated changes in the synaptic terminals, such as a reduced
quantal content and the occasional appearance of 'giant' miniature endplate
potentials (MEPPs). Likewise, in ultrastructure, the axotomised synaptic endplates in
Wltf neurons are different from wild type mice. None of the classical signs of
degeneration such as mitochondrial swelling and disruption can be found during
degeneration, but some large vesicles as large as 130nm appear in the pre-synaptic
membrane. This perhaps suggests that the synaptic vesicle retrieval mechanism has
been impaired during nerve terminal withdrawal in the Wlcf mice (Ribchester et al.,
1995, Gillingwater et al., 2001). These authors also draw attention to the remarkable
resemblance between motor nerve terminal "degeneration" as it appears in Wlcf
mice and the natural process of synapse elimination, which underlies the remodeling
of neuromuscular connections during normal postnatal development. Both
procedures appear to be qualitatively distinct from Wallerian degeneration of
synaptic terminals in wild-type mice.
1.10 Synapse degeneration in the Older (> 7months)
Wlcf mice
In 1992, Perry et al first elucidated that the rate of degeneration slowed by the
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Wlcf gene increased with the age of the animals. In the four weeks old Wlcf mouse
nerve stimulation produced compound action potentials (CAP) that could be evoked
in the distal nerve stump after section for up to 3 weeks. In 1-year-old mice however,
the authors didn't find any action potentials 5 days after nerve section, this was
similar to the wild type mice, where all axons were completely degenerated by 5
days after axotomy. In the young Wlcf mice, functional neuromuscular transmission
is presented in all muscle fibres up to 3 days after nerve section, while, in WW5 mice
more than 8 weeks old, the neuromuscular transmission is lost after around 2 days.
On the other hand, data published by Gillingwater et al (2002) suggest that,
rather than axonal degeneration, the degeneration of synaptic terminals in the Wlcf
mice is age dependent. When Wlcf mice are over 4 months old, the morphology of
nerve terminal degeneration reverts to that in wild type mice (Gillingwater et al.,
2002). In contrast to these studies, Crawford et al (1995) proposed that both axonal
loss and synapse loss were independent of age.
Ultrastructural analysis of the response to axotomy in motor nerve terminals of
4-month-old Wlcf mice showed swollen and distorted mitochondria, but intact
synaptic vesicles. In ultrastructural analysis of synaptic boutons originating from the
same motor nerve axon, some boutons contained abnormal mitochondria, but other
boutons did not. In 7 months old Wlcf mice, at 2 days post axotomy, more classical
degenerative characteristics were found, such as disrupted mitochondria, reduced
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synaptic vesicle densities, membrane disruption, and terminal Schwann cell
phagocytosis. From morphological analysis of preparations observed by
immunocytochemical staining very few partially-occupied endplates were seen,
which reflects that endplates degeneration is a rapid process in old Wlcf mice. Most
endplates were either fully occupied or vacant, In 4 months old Wlcf mice about 35%
endplates were occupied following 3 days axotomy, but in 7 months old mice, fewer
than 5% occupied endplates remained by 3 days. Thus, it was proposed that the
synapses were removed synchronously in the older Wlcf mice. Arguably, this could
simply mean that synaptic degeneration is more rapid in wild type mice, such that
few partially-occupied endplates are observed at any given time point. However, at
present this interpretation can not be distinguished from a qualitatively different
mechanism.
1.11 Compartmental Neurodegeneration
Under normal circumstances, death of the cell body is followed by rapid
degeneration of other neuronal compartments: dendrites, axons and synaptic
terminals. With the discovery of phenotype in Wlcf mutant mice, a dissociation
between normal cell body apoptosis and Wallerian degeneration was revealed (Lunn
et al., 1989; Mack et al., 2001). Wallerian degeneration is absent or delayed after
axotomy in these mice. Further studies of Wlcf mice suggested that soma, axons and
synapse represent independent neurodegeneration compartments (Gillingwater and
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Ribchester, 2001; 2002, and Figure 1.4).
All evidence obtained to date suggests that the Wlcf gene protects the axons and
synapses but not cell bodies (Gillingwater and Ribchester, 2001; 2003, Wang et al.,
2006). For instance, conversely Wlds expression does not protect cell bodies from
apoptosis (Adalbert et al., 2006), it has been found that when genes such as Bcl-2 are
overexpressed, apoptosis is inhibited, but Wallerian degeneration is not. Bcl-2 is
one of three main regulators of apoptosis in neurons (Gillingwater and Ribchester,
2001). However, Burne et al (1996) and Sagot et al (1995) showed that in retinal
ganglion cells and facial and phrenic motorneurons respectively overexpression of
the human Bcl-2 protein protected cell bodies, but there was no effect on the rate of
axonal degeneration. Thus, Bcl-2 selectively protects cell bodies while Wlcf
selectively protect axons.
Might nerve terminals be a distinct neurodegenerative compartment? Motor
nerve terminals are among the first junction to describe the degeneration after nerve
injury (Miledi and Slater, 1968; 1970). They are weakly protected in Wlcfmice that
is, they degenerate more slowly than in wild-type mice and more rapidly than axons
in Wlcf mice. However, as yet no genes have been identified that selectively protect
motor nerve terminals to the same extent as Wlcf protects axons. Cregan et al (1999),
Lebanc et al (1999), and Kuida (2000), suggested that Caspases 3, 6, and 9 regulate
apoptotic cell death in neuron. Mattson et al (1998) found no caspase activation in
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axons, and instead reported that caspases were activated in cortical synaptosome. But
it remains to be seen whether mutation in these signaling pathway leads to synaptic
protection. Thus the independence of synaptic terminal degeneration from axonal
degeneration remains to be firmly established.
It has been suggested that the withdrawal of nerve terminals in Wlct mice is
similar to the pattern of synapse elimination that occurs at NMJs during postnatal
development and reinnervation in mice (Sanes and Lichtman, 1999; Gillingwater et
al., 2001; 2002; 2003). Synaptic elimination occurs at a normal rate in neonatal Wlct
mice (Parson et al., 1997). Gillingwater et al (2002) also found that age is a
significant factor, influencing the rate and pattern of synaptic degeneration in Wlct
mice after axotomy (Figure 1.5). Another variable is the length of severed axons. An
open question also remains as to the role of neuromuscular activity in the
maintenance of axotomised nerve stumps. It is perhaps reasonable to expect this,
because activity influences other aspects of neuromuscular synaptic plasticity,
including synapse elimination, sprouting and nerve regeneration (see for example,
Richester & Taxt 1984, Ribchester, 1988, Barry & Ribchester, 1995, Costanzo et al.,
2000).
1.12 Neurodegenerative disease
Many recent studies have shown that synaptic degeneration is among the first
step in the development of several types of neurodegenerative diseases. For example,
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Alzheimer's disease is now thought to be primarily a disease of synapses (Mattson et
al., 1999; Selkoe, 2002). In Parkinson's disease, and some variants of Alzheimer's
disease dementia with Lewy bodies, a-synuclein is known to play an important role
in neurodegeneration (George, 2001; Lotharius and Brundin, 2002; Kotzbauer et al,
2001; Iwai, 2000). Transgenic overexpression of the human presynaptic protein
a-synuclein in mice resulted in a retraction of nerve terminals from dendritic spines
in the brain (Van der putten et al., 2000). Gillingwater et al (2006a) have shown that
in the young Wlct mice morphological degeneration of nerve terminals following
axotomy in the CNS is distinct from that in the PNS. Although they were still
delayed by the Wlcf gene following axotomy, the pattern of synaptic degeneration
reverted back to that in the PNS of wild type mice. The axons nonetheless remained
well-protected by the Wlct gene. These new findings in the CNS of Wlct mice could
provide new directions for investigating Parkinson's, and Alzheimer's diseases, in
which synaptic dysfunction and degeneration are also thought to precede neuronal
cell death (Selkoe, 2002, Isacson et al., 2003).
Motor neuron diseases (MND) are a kind of progressive neurological disorder.
Motor neurons, the cells that control speaking, walking, breathing and swallowing,
are destroyed. They are a group of chronic progressive diseases (Gros-Louis et al.,
2006), for which there is no effective treatment or cure. Amyotrophic lateral
sclerosis (ALS) is an adult-onset form of motor neuron disease, also called Lou
Gehrig's disease. It was first described by the French neurologist Jean-Martin
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Charcot in 1869. The main hallmark of ALS is the progressive degeneration of
neurons in the spinal cord and motor cortex, especially motor nerves that form
corticospinal tracts.
ALS is classified into two forms, such as 90% of cases are sporadic ALS
(SALS), and as they are not associated with a family history, and 10% are familial
ALS (FALS), which are inherited. Among familial cases, nearly 20% are caused by
dominantly inherited mutations in the protein Cu/Zn superoxide dismutase (SOD1)
(Bruijn et al., 2004). Sporadic and familial forms display a similar clinical pathology,
hence suggesting a common pathogenesis (Bruijin et al., 2004; Gonzalez de Aguilar
et al., 2007). However, the exact cause in most cases is still unknown.
Since the 20% of familial ALS cases are caused by an inherited mutation in the
protein Cu/Zn superoxide dismutase (SOD1) (Rosen et al 1993), animal models of
ALS, such as SOD1 mice, provide a unique opportunity to study the mechanism of
familial and sporadic ALS diseases, by virtue the conspicuous pathological and
clinical similarity between them. To date there have been many findings based on
experiments on SOD1 mice, from neuronal to nonneuronal cells, from pathology to
ultrastructure. Pramatarova et al (2001) and Boillee et al (2006) have shown that
changing SOD1 expression only in motor neurons does not trigger ALS disease or
alter the lifespan of animals. Ultrastructure, studies have shown, for example,
accumulation of manganese superoxide dismutase 2 in the mitochondrial matrix,
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which exacerbates disease in transgenic SOD1 mice. (Andreassen et al., 2000).
Accumulation and abnormal assembly of neurofilaments are found in familial ALS
(Hirane, 1984). Furthermore, life span is increased in the SODlG37 line by increasing
expression of NF-H in the neuron cell body. Dynein, a microtubule cytoplasmic
motor protein involved in processes of vesicular transport, cell division, and
retrograde transport in the axon (Levy and Holzbaur, 2006) has also been studied.
Overexpression of an ALS-linked mutant dynactin, which activates dynein is
sufficient to induce motor neuron degeneration (Gonzalez de Aguilar et al., 2007).
When microglia activation is blocked by minocycline, an antibiotic, ALS disease is
slowed in the ALS mice. (Yrjanheikki et al., 1999; Kriz et al., 2002; Zhu et al., 2002)
Moreover some growth factors and neurotrophic factors might play a role in ALS,
for example, vascular endothelial growth factor (VEGF) decreases the age at onset of
disease and life span, when its own levels were reduced in SOD 1093A transgenic
mice (Bruijin et al., 2004). Gene mutation, CNTF, a neurotrophic factor, have also
been found in ALS patients (Giess, 2002). From biochemical analysis, several
hypotheses have been proposed such as, aberrant chemistry of the active copper and
zinc sites of the misfolded enzyme causing ALS (Beckman et al., 1993).
Although there have been many discoveries made from studies of SOD1 mice,
none of these has yet been translated into effective treatment for ALS. Given that
ALS is thought to be a complicated and "systemic disease" (Gonzalez de Aguilar et
al., 2007), finding effective treatments for ALS remains a challenge in the future, but
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one in which the SOD1 mouse model is still likely to play a significant role.
Nevertheless, studying motor neuron degeneration at the NMJs of SOD1 mice
may yield some new insights that aid our understanding of ALS disease in SOD1
mice. Schaefer et al (2005) demonstrated in the SODlc,93A1 mouse model that
degenerative and regenerative changes both occur in different branches of the same
motor neuron pool. Hence, protecting compensatory growth could be a new target in
disease treatment. Moreover, Pun et al (2006) suggest that different types of motor
neurons show distinct responses in the disease. For instance, fast fatiguable axons
(FF) degenerate more rapidly than axons of fast-fatigue (FR) resistant and slow (S)
motor neuron. These findings indicate that a fuller understanding of the mechanism
of disease in SOD1 mice may well be accomplished in due course.
Discovery of Wlcf mice presents potential benefit for treatment of ALS mice,
since the Wlcf gene protects against both axonal and synaptic degeneration. Studies
have shown that when pmn mice are crossed with Wlcf mutant mice, the synapse loss
and neuronal death are reduced (Ferri et al., 2003). Thus it was anticipated that
crossing SOD1 mice with Wlcf might be have a similar result, since progressive
synaptic loss had been found in the early stages of ALS disease in the SOD1
transgenic mouse (Maselli et al., 1993; Frey et al., 2000; Gillingwater et al., 2003)
Unfortunately, this result was not obtained. Only modestly prolonged survival and
delayed denervation could be found at the neuromuscular junction in S0D1G93A>
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when crossed with Wlcf mice (Fischer, 2005). Evidently, the Wlcf gene can not delay
regression of axons and synapses in SOD1 mice.
In conclusion, although axotomy-induced retraction of motor nerve terminals in
the Wlcf mutant has provided new possibilities for using neuromuscular preparations
to investigate synaptic form and function in the early stages of neurodegeneration,
the utilization of the Wlcf phenotype to protect against disease has yet to reach
fruition. This is in part for the reason that our understanding of the causes and
limitations of the Wlcf phenotype is yet incomplete. .
1.13 Aims of the present study
This thesis is primarily concerned with those features that significantly alter the
strength, pattern and rate of degeneration of neuromuscular synapses in Wlcf mice. I
have used conventional fluorescence microscopy, confocal microscopy and
immunochemical staining techniques to find out more about the gene-dose and
age-dependent effects of the gene on the degeneration of axons and synapses in the
Wlcf mice, in an endeavour to discover the possible relationships between theses
features.
My aim in this thesis is to advance our knowledge of nerve degeneration
mechanisms and its inhibition by the Wlcf gene, focusing in particular on synapse
degeneration. I developed a new analytical method, representing synaptic
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degeneration under different conditions in the form of "Polyhedral Degeneration
Diagrams" (PDD). Analysis of synaptic degeneration using PDD facilitates the
interpretation of different patterns of degeneration of axons and nerve terminals,
extending our knowledge of the neural degeneration patterns and how it is regulated,
for example by the Wlcf gene dose. The specific objectives of this thesis are three
-fold:
1. To extend knowledge and understanding of the degeneration of axons and
synapses in normal and in homozygous and heterozygous Wlcf mice following
axotomy. Qualitative and quantitative immuncytochemical staining and confocal
microscopy and conventional fluorescent microscopy were carried out on nerve
terminal preparations of young C57/B16 mice, young (l-2month) homozygous Wlcf
mice, and young heterozygous Wlcf mice. The main purpose of these experiments
was to obtain evidence that would further evaluate the hypothesis that
neuromuscular synaptic protection is more sensitive than axon protection to the
Wlcf gene dose. PDD were used to analyse the patterns of synaptic degeneration
among these types of mice. Wld18 antibody was used to stain the Wlds protein in
cerebella granule cells, and fluorescence intensity from labelled secondary
antibodies was determined, as a measure of Wlds protein
2. To extend previous studies of nerve terminal degeneration and its
age-dependence in Wlcf mice. Data and PDD analysis from old (>7months)
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axotomised Wlcf NMJs at different time points were compared with those in young
homozygous and heterozygous Wlcf mice. Furthermore, I measured protein
expression in cerebullar granule cells in these mice to examine whether
age-dependent loss of synaptic protection is related to changes in levels of Wlcf
protein expression.
3. To test the hypothesis that synaptic degeneration in Wlcf mice can be altered by
factors such as nerve stump length and blocking neurotransmitter release. In the
first experiment, degeneration of nerve terminals at Wlcf mouse NMJs following
tibial nerve section was compared with that following sciatic nerve section. I
compared the effect of injection of botulinum toxin (BoTox) in young and old mice.
The results presented in the following chapters support a compartmental model
of neurodegeneration, in which Wlcf synapses are much more sensitive than axons
to the gene dose of Wlcf. The findings also suggest that loss of synaptic protection
in more mature Wlcf mice could be explained by an age dependent decrease in Wlds
protein expression. Neither nerve stump length nor activity appeared to mitigate the
rate of synaptic degeneration to any great extent.
Preliminary reports of my research were presented at international meetings of
the Federation of European Neuroscience Societies (Fens, 2004) and the Society for
Neuroscience (SFN, 2005). See Appendix II for Abstracts.
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Figure 1.1
Schematic diagram of compartmental model of neurodegeneration showing distinct
degeneration in cell body, axons and synapses of neurons (blue=cell body; purple =
axon; yellow = synaptic terminals). From Gillingwater et al 2003
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Apoptosis (BCI-2/Bax) Wallerian degeneration (Ufd2/Nmnat)
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Figure 1.3
85-kb Wlcf triplication repeat unit with exons (Nmnat, Rbp7, Ube4b) In WlcF,
three adjacent repeat units are shown to explain (a) how Ube4b and Nmnat are
brought together to form a chimeric gene, (b) how Rbp7 is present at three points in




































Axon protection by the Wlct gene is gene-dose dependent. Axon preservation is
associated with the expression level of Wlds protein. Black circles, white circles and
crosses represent 3, 5 and 14 days post axotomy respectively. From Mack et al 2001
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Transgenic Wld protein expression (%Wlds)
From Mack et al. 2001 Nat Neurosci.1199-206.
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Figure 1.5
Schematic diagram showing different models of synaptic degeneration from
developmental synapse elimination (left) to Wallerian degeneration (right). In the
middle two are the responses to axotomy in young Wlcf mice (middle left) and
mature Wlcf mice (middle right). Synapse degeneration in young Wlcf mice
resembles wild type mice. In mature mice the synapse degeneration resembles wild
type mice, although axons are protected well by the Wlcf gene.
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The protocols discussed in this section are common to all chapters. Methods
specific to individual chapters are briefly described in the relevant chapters.
2.1.1 Animals and Animal Care
Male and female young and old YFP16IWlct mice (5-10 weeks old defined as
'young', 7 months old defined as 'old' ), young heterozygous YFP16IWldt mice
(Wlcf crossbred with Balb/c mice), young YFP16/B16 mice (2 months old) and
young CFP/Wlcf mice were used for experiments. Animals were housed in cages of
5 or less with free access to food and water. Environmental conditions were those of
a standard animal house.
YFP/CFP transgenic mice: Two kinds of YFP mice were used: YFP16
transgenic mice which express the yellow-green fluorescent protein (YFP) in all
axons, and YFP-H transgenic mice which are expressed in very few axons (< 10%).
CFP: CFP transgenic mice which express cyan fluorescent proteins in their axons,
nerve terminals, and dendrites (Feng et al., 2000). There is no expression of
fluorescent protein in either myelinating or terminal Schwann cells in these mouse




All surgical procedures were undertaken under aseptic conditions and were
fully licensed by the Home Office (PIL: 60/9199; PPP 60/3277). Sterile instruments,
and cloths were used during surgical procedures.
2.1.3 Surgical Procedures
All surgical procedures were carried out under licence in accordance with the
Animal (Scientific Procedures) Act of 1986.
Anaesthesia
The animal was placed in a sealed Perspex chamber into which Halothane
(Rhone-Poulenc Rorer, Ltd. France) at 1-5% in N20/02(l:l) was delivered, using a
Fluovac System (International Market Supply, UK). Once the animal was
unconscious, a toe-pinch reflex test was used to assess depth of anesthesia. It was
then transferred to the operation table where anaesthesia was continued via a face
mask. The level of halothane was reduced at this point to 1-3% in N20/02(l:l). The
flow rate was adjusted during the whole procedure to maintain deep anaesthesia.
2.1.4 Nerve Cut
The operative areas of the animal were shaved before incisions were made.
Either the sciatic or the tibial nerve was exposed by using sharp scissors, and a 1-2
mm section of nerve was removed. The wounds were closed and sutured using 6/0
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silk suture (Ethicon). Lumbrical muscles were examined 6 hours - 9 hours later. The
distance between the lesion sites in the sciatic and tibial nerve was almost 2cm
(Figure 2.1). These lesion sites are the same as those used to test for nerve - stump
length effects in a previous study (Ribchester et al, 1995).
2 cm 2 cm DL muscle
Figure 2.1 Diagram of transaction sites between tibial nerve and sciatic nerve
2.1.5 Animal Sacrifice
All animals were killed by cervical dislocation, in accordance with schedule 1
of the licensing regulations provided by the Home Office.
2.2 Isolation of Muscles
After sacrificing the mice, hind limbs were removed and the four deep
lumbrical muscles in both hind feet were dissected, in mammalian physiological
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saline concentrations in millimolar: NaCl 120; KC1 5; CaCl2 2; NaH2P04 0.4
NaHCC>3 23.8; D-glucose 5.6). Dissected muscles were pinned out in Sylgard-coated
Petri dishes, using 0.2mm diameter minutien pins.
2.3 Neuromuscular Junction (NMJ) Staining
(Immunocytochemistry)
Lumbrical muscles pinned out in Sylgard coated Petri dishes were fixed in 4 %
paraformaldehyde (Sigma) for 30-45 mins before labeling acetycholine receptors
with TRITC-a-BTX (Molecular Probes) in 0.2M PBS. The preparation was placed
on a rocking platform to agitate the buffering solution for 30 mins in the dark. After
discarding the a-BTX solution, the muscles were washed in PBS (0.01 M phosphate
and 0.9% NaCl, PH7.5). Muscles were then incubated in primary monoclonal
antibodies against 165 kDa neurofilament proteins (2H3), and the synaptic vesicle
protein (SV2), both primary antibodies obtained from (Development Studies
Hybridoms Bank, Iowa).
The primary antibodies were then labeled with FITC-conjugated rabbit (Dako
A/S company, Denmark) anti-mouse secondary antibody. Finally the muscles were
mounted on glass slides for imaging.
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2.4 Visualisation of NMJs Staining Using Confocal
Microscopy
Since the main technique used in the present thesis work was fluorescence
confocal microscopy, a brief review is provided here to describe this method.










The phenomenon that molecules absorb light of energy (475nm blue, for
example) and emit light of lower energy (515nm green, for example), is commonly
called fluorescence. The emitted light typically has a larger wavelength (Stake's
shift), since emitted photons have less energy than that used to propel them into the
excited state. The fluorescence process is sketched in Fig.2.2 Incident blue-light
photons excite an electron from a ground state to one of the available excited energy
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levels of the molecule. The excited electron may partially lose its energy by heat
(infrared light), and then makes a transition back to the ground state, emitting green
light. Fluorescein acts this way and is a commonly used fluorophore for staining a
sample for fluorescence microscopy.
YFP has an excitation maximum of 520nm and an emission maximum of
532nm; CFP has an excitation maximum of 430nm and an emission maximum Of
















In a typical flurorescence microscope, as shown in Fig 2.3, Light from a
mercury vapor lamp (blue, for example) is filtered to yield an appropriate
wavelength. This light enters the microscope and hits a dichroic mirror. This
reflects light at the excitation wavelength onto the specimen. The excitation (blue,
for example) excites fluorescence (green) within molecules in the specimen. The
emitted green light is collected by the objective lens and passes through the dichroic
mirror, and an emission filter which blocks stray excitation wavelengths forming an
image through the eyepiece. For YFP fluorescence, a conventional FITC filter cube
is adequate and was used in this study. A standard TRITC filter cube was used to
view labeled Ach receptors (via TRITC-a-BTX binding). For CFP fluorescence a
customized filter block, comparing a 435nm excitation filter, 475nm dichroic mirror
and 515nm emission filter was used.
In conventional fluorescence microscopy, the entire view of the sample is
completely illuminated, making the whole region fluoresce at the same time. The
objective collects fluorescence light from whole region, and then forms an image
through the eyepiece. Out-of-focus regions above and below the focal plane
contribute to a background haze in the resulting image.
2.4.3 Confocal Microscopy
In order to create less haze and better contrast images from the sample, confocal
fluorescence microscopy was developed as an enhancement to conventional
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fluorescence microscopy.
The first confocal microscope was invented by Marvin Minsky in the mid-1950s
(Minsky, 1988). However, his invention remained unnoticed for a long time, mainly
due to the lack of good imaging technology at that time. With the invention of the
laser and digital image processing ,confocal microscopes became practical during the
late 1970s and the 1980s (Amos and White., 2003). A nice summary about the
history and principle of confocal fluorescence microscopy was given by J. W.
Lichtman in 1994 (Lichtman, 1994).
The main improvement in a confocal microscope is obtained by placing a
pinhole aperture in front of a detector. The pinhole is placed at the exact position of
the image of focal point of the objective lens on the sample. Thus, the pinhole is
conjugate to the focal point of the lens; hence the name "confocal pinhole".
Fluorescent light from the focal point on the sample will pass through the pinhole
and thereby reaches the detector. In contrast, most of the light from location above
and below in the focal point are deflected outside the pinhole and are blocked by the
screen. So the detected light is mainly from the focal point region, resulting in a
sharp image of that region.
In a confocal microscope, only one point of the sample is observed at any given
instant. Complete data from a specimen are obtained by laterally scanning a focused
laser beam across the specimen. This point of illumination is brought to focus in the
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specimen by the objective lens, and scanned using some form of scanning device
under computer control. The sequences of points of light from the specimen are
detected by a photomultiplier tube (PMT) though the pinhole, and the output from



















The confocal microscopy offers several advantages over conventional optical
microscopy, including shallow depth of field, elimination of out-of-focus glare, and
the ability to collect serial optical sections from thick specimens. In the biomedical
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sciences, a major application of confocal microscopy involves imaging either fixed
or living cells and tissues that have usually been labeled with one or more
fluorescent probes. These advantages were used to good effect in my studies.
2.5 Confocal Images of NMJs
My samples were viewed in a Bio-Rad-Radiance 2000 confocal laser scanning
unit, configured on an upright Nikon Eclipse E600FN microscope. Multi-line Argon
(457nm, 477, 488 and 514nm), Green HeNe (543nm) and Red Diode lasers (637nm)
were used as laser light sources. The external detector unit with built-in
photomultiplier was connected to the microscope via a fiber optic-cable. The
microscope was connected to a Dell PC with systems Control Boards and Lasersharp
Application Software, including Image Acquisition, Scan Settings, Rea-time image
calculation, Hardware Control, Image Display, Image Processing, Image Analysis,
and 3D Visualization. Images were enhanced and analyzed using Adobe Photoshop
before being printed on an Epson Stylus Colour 900 printer.
2.6 Quantification of Immunocytochemically Labeled
Neuromuscular Junctions
All NMJs on every slide were counted and analysed. Each NMJ was analysed
by the proportion of postsynaptic terminals contacted by presynaptic terminals, and
divided into one of the following categories: 0% vacant, l%-25% occupied,
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26%-50% occupied, 51%-75% occupied, 76%-99% occupied, 100% fully occupied.
All data were inserted into a Microsoft Excel spreadsheet for further analysis, and
graphs were produced in Excel and GraphPad Prism.
2.6.1 Method of Quantification of Synaptic Degeneration
Scion Image programme (based on NIH image and downloaded from
www.scioncorp.com) was used to measure the occupancy of the nerve terminals.
First, two different channels (green/red) of synaptic terminals were taken under
confocal microscopy (Figure 2.5 A). Second, the number of pixels in each of
different channel images over the defined endplate area was measured by using
Scion image programme (Figure B&C). Third, the occupancy of each endplate was
calculated: Occupancy% = Green Pixel/ Red Pixel* 100. In practice, the semi-quan¬
titative assessment of endplate occupancy formed a sufficient basis for most of the
analysis.
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Figure 2.5 Scion Image Quantification of Nerve Terminals
(A) Confocal images of a NMJ in the green and red channels, alongside a
merged image.
(B) An image of a single nerve terminal from the green channel exposed into
Scion Image.




2.6.2 Polyhedral Degeneration Diagram (PDD)
Further analysis of the possible relationships between states of innervations was
attempted using a model geometric method. I first classified the state of innervation
and occupancy of neuromuscular junctions in different types of animals following
axotomy, I then constructed diagram to represent these states. In my PDD method,
circles were placed at the apices of polyhedra, each representing a different state of
synaptic degeneration. Using Microscope PowerPoint, the diameter of the circles
was defined by the percentage (scaled to 1/32 i.e. l%=l/32) of neuromuscular
junctions in each category.1 Arrows pointed out the possible links between the
different states. The relative proportion of terminal in the given states at different
time points allowed me to infer the most likely 'trajectories' of degeneration from
the fully occupied to the vacant states. See Chapter 6 for more details.
2.7 Immunofluorescent Staining for Wlds Protein on
Cerebellum Slices
Following killing the animals, the skull was cut open with scissors and the
brains were removed and rapidly transfer into cold oxygenated ACSF (See Appendix
I for composition). To form a flat edge, one side of the brain was removed, and the
flat edge was stuck with superglue at the bottom of a slicing chamber. Sagital slices
1 The PowerPoint version used for that measurement employ inches as a unit of
length rather than centimeter, but since the calculation gave a dimensionless result
this did not matter.
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100pm thick were cut, and immediately placed in 4% paraformaldehyde solution to
fix for 20 mins. Section were then twice washed in 0.1M PBS, the brain slices were
incubated in freshly-made blocking solution overnight in cold-room (4°C), and the
solution was placed on a rocking platform to agitate the solution. After discarding
the blocking solution, the brain slices were incubated overnight in rabbit-primary
antibody Wld18 (generous gift from Dr. M P Coleman). This antibody recognizes the
Wlds protein uniquely and with high affinity. The epitope corresponds to an 18
amino acid polypeptide linking the N70 Ube4b and Nmnat region, corresponding to
an mRNA which is not normally translated in wild-type mice. The primary antibody
was then labeled with TRITC or FITC labeled anti-rabbit secondary antibody
overnight. After a quick wash in 0.1 M PBS three times, Topro-3 was applied into
the solution for 10 mins to label nuclear DNA. After a quick wash in 0.1M PBS, the
brain slices were mounted in mowiol (Calbiochem) for confocal imaging. See the
end of chapter for detailed protocol.
2.8 Statistical Analysis
Unless otherwise stated, the statistical tests were unpaired t-tests for continous
parametric data and unpaired Mann-Whitney test for discrete or categorical (i.e.
non-parametric) data. The analysis was performed using Prism (Graphpad Software)
running on windows XP on a Dell computer. Detailed protocols for immunostaining
and image analysis are listed in Appendix I.
65
3. Analysis of Neuromuscular Synaptic
Degeneration in Homozygous and
Heterozygous young Wlcf mice
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3.1 Introduction
Wallerian degeneration refers to the distal axonal fragmentation and
degeneration that occur after an axon is separated from its cell soma (Vial, 1958;
Nicholls et al., 1992). In the mammalian neuromuscular junction, the degeneration of
nerve terminals occurs earlier than the degeneration of axons induced by axotomy
(Birks et al., 1960; Miledi and Slater, 1970). In the spontaneous mutant Wlcf mouse,
degeneration of axons and synaptic terminals is significantly delayed after axotomy
(Lunn et al., 1989; Ribchester et al., 1995). Using vital dye labeling,
immunocytochemistry, and electrophysiology, it has been shown that axotomised
Wlcf motor nerve terminals, as well as axons, undergo a process described as
piecemeal withdrawal, which appears to be distinct from classical Wallerian
degeneration (Mattison et al., 1996; Parson et al., 1998; Ribchester et al., 1999).
In 1998, Coleman et al first showed that the Wlcf mutation comprises an 85 kb
tandem triplication of genes, containing exons of three different genes, Ube4b (the
mammalian homologue of ubiquitin fusion degradation protein 2(Ufd2)), Nmnat
(nicotinamide mononucleotide adenylyl transferase), and a novel member of the
cellular retinoid-binding protein family (Rbp7). One end of Ube4b (the code for the
N-terminal 70 amino acids) and the complete sequence of Nmnat form a chimeric
gene with an open reading frame coding for a 43 kDa fusion protein. Subsequently
Mack et al (2001) showed, using transgenic lines with different levels of Wlcf
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expression, that the extent of axon preservation is strongly dependent on the
expression level of the chimeric Wlcf protein. However, heterozgyous Wlcf mice,
which have half the 'gene-dose', and express about half as much Wlcf protein as
homozygotes, show little difference in protection of their axons compared to the
young homozygous Wlcf mice. On the other hand, motor nerve terminals appear to
degenerate rapidly in Wlcf heterozygotes (Gillingwater et al 2002). In this chapter, I
set out to measure and analyse the sensitivity of synaptic degeneration in greater
detail.
3.2 Results
3.2.1 Morphology of the Neuromuscular Junctions in Wld5
Mice
Time course of synaptic degeneration in young homozygous Wl<f mice
Sixty-four lumbrical muscles were taken at 5, 7, 9 and 11 days post bilateral
tibial axotomy in CFP/Wlcf mice (N=9 mice). The postsynaptic ACh receptors were
labeled with TRITC-a-BTX (Figure 3.1). In order to obtain a clear image and more
accurate data, every NMJ in each muscle that presented en face was individually
assessed as to the level of occupancy, confocal microscopy and Scion Image
software were used (see chapter 2). Confocal projection images facilitate this process
by compressing all the endplates into a single digital focal plane; avoid the need to
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image each endplate, most of which were in different optical sections. At each
successive time point following axotomy, the number of vacant endplates was
increased (Figure 3.2). For example, at 7days axotomy 34.61% mean ± 8.25 S.E.M
of endplates were vacant; and by 9 days 55.08% ± 8.58 were vacant (Figure 3.3).
The data confirms previous findings reported by Gillingwater et al (2002).
Therefore, all subsequent analyses were carried out using mice expressing
fluorescence protein in motor neurons.
3.2.2 Morphology of Neuromuscular Junctions in Different
Types of Mice
Axons and NMJs show different sensitivities to Wldf gene dose
Tibial nerve labeled by YFP expression was taken from each of wild-type, Wlcf
heterozygous, and Wlcf homozygous mice at 4 days following axotomy, and
compared with unoperated mice. Images are shown in the Figure 3.4. Axons
degenerated rapidly in wild-type mice (Figure3.4 B), but were well protected from
degeneration in both heterozygous and homozygous Wlcf mice 4 days after axotomy
(Figure 3.4 C, D). In contrast to axon preservation, NMJ preservation was different.
NMJs are from one young heterozygous Wlcf and one wild-type at 1 day after
axotomy, and one young Wlcf mouse at 5 days after axotomy are shown in Figure
3.5. Endplates in unoperated muscles were fully occupied by their motor nerve
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terminals (Figure A). Motor nerve terminals degenerate rapidly and synchronously in
Wlcf heterozygotes and wild-type mice (Figure 3.5 B, C), but progressively vacated
motor endplates following axotomy in Wlcf homozygotes (Figure 3.5 D).
Interestingly, these images also suggest that intramuscular axonal branches are more
vulnerable to degeneration than their parent axons in the tibial nerve (see below
Figure 3.10).
3.2.3 Quantification of Endpiate Occupancy in Wild-type,
Heterozygous and Homozygous Wlcf mice
Wild-type mice
NMJs from 9 unilateral sciatic axotomised wild-type mice were studied at 6
hours, 12 hours, and 14.5 hours and 17 hours respectively. In total thirty-three deep
lumbrical muscles were dissected from these mice. Nerve terminal morphology was
assessed from the endogenous YFP fluorescence and endplates were counterstained
with TRITC-a-BTX. Nerve terminals and axons degenerated quickly in these mice.
After 14.5 hours fewer than 10% of endplates were occupied, At 17 hours, all nerve
terminals had degenerated completely. The complete motor innervation in wild type
mice was reconstructed by The Adobe Photoshop at 6 hours post unilateral sciatic




Fifth-six muscles were taken from sixteen YFP16 BalbcIWlcf mice (5-8 weeks
old). The left sciatic nerve in these mice was cut unilaterally at different time points:
6 hours, 12 hours, 17hours, 20 hours and 24 hours before sacrificing the mice. All
muscles were labeled with TRITC a- BTX. From 6 hours to 24 hours, a few
endplates started to degenerate at 6 hours axotomy, after then the nerve terminals
degenerated dramatically, fully occupied and vacant endplates could be found, but
very few endplates were partially occupied and all endplates became vacant 3 days
after axotomy (Figure 3.5-3.9). Some axons branching on the NMJs had become
fragmented. The biggest change in the number of occupied endplates occurred
between 12 and 20 hours after axotomy. Remarkably, the sensory axons were better
protected by Wlcf gene than the motor axons in heterozygous YFP16/MJ7Balbe
mice (Fig 3.10). Montage pictures showed that in the whole NMJ of
YFP16/WZ</7Balbc mice, axons were still intact even after 4 days axotomy, while
both synapses and the branches connected with synapses had already completely
degenerated.
Confocal montage pictures allowed comparison of the patterns of degeneration
in young heterozygous Wlcf mice and wild-type mice at different time points. It
appeared that synaptic degeneration in heterozygous Wlcf mice was only slightly
delayed by the Wlcf protein in comparison to wild type mice (Figure3.7-3.10).
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Quantification of synaptic degeneration in the three different types of mice is shown
in the Figure 3.11. There were only slight differences in the degeneration of nerve
terminals in the heterozygous Wlct mice and wild-type mice, and synaptic
degeneration in homozygous Wlct mice was much slower. In heterozygotes, it
appeared that in addition to motor nerve terminals, intramuscular axon branches also
degenerated within 24 hours in most cases, in contrast to the preservation of axons in
the tibial nerve in heterozygous Wlct mice. This difference is evident also in Fig 3.10,
and merits further investigation in future studies.
Homozygous Wlcf mice
In young YFP16/Wlct mice, twenty-nine lumbrical muscles were taken after 3,
5, 7, and 9 days post unilateral sciatic nerve section. The nerve terminals
degenerated gradually. Most endplates were fully occupied or partially occupied
after axotomy. Data in Figure 3.8 show the time course of synaptic degeneration in
Wlct homozygous mice. In 3 days axotomised lumbrical muscle preparations,
10.77% ± 4.04 of endplates were vacant by 5 days vacancy had increased to 28.22%
± 5.77 of endplates, then 59.32% ±3.84 at 7days, and to 75.53% ± 2.3% at 9 days.
The results of time course of synaptic degeneration in these three different
axotomised mice lines showed that Wlds protein does have a protective effect on
synaptic degeneration, even when the dose is reduced. For example, the amount of
synaptic degeneration at 17 hours was slightly lower in heterozygous Wlct mice
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compared with wild type mice (Fig 3.11). Perhaps more compelling, occasionally
there were terminals that were well-preserved at 36hrs axotomy in Wlct
heterozygotes when this occurred, the preservation seems to affect all the terminals
in the protected motor unit. Perhaps this indicates that there is some variability in the
level of Wlct gene expression between motor neurons.
However, there was a large difference in synaptic protection comparing either
heterozygous or wild-type mice with Wlct homozgyotes. Degeneration of synapses
was almost 10 times slower in the homozygous Wlct mice. Whereas in wild-type or
heterozygous mice, the nerve terminals degenerated completely after 17 hours in
wild-type mice. However, I did occasionally observe protection, as a few nerve
terminals were occupied 24 hours after axotomy in heterozygous Wlct mice.
Therefore, in comparison to the axons, NMJs are clearly very sensitive to the gene
dose.
3.2.4 Analysis Using Polyhedral Degeneration Diagram (PDD)
The above analysis gave a good indication of differences in the rate of synaptic
degeneration in the different groups of mice that were studied. Polyhedral
Degeneration Diagrams (PDD) was used to examine for difference in the pattern of
synaptic degeneration. Confocal micrographs show the definitions of the five states
of axonal and synaptic degeneration (Fig 3.12). Innervation states of axons and
synapses during neuronal degeneration were defined as follows: O represents an
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intact axon connected with a fully occupied endplate ; CP represent partial
occupancy with the synaptic terminal still connected to the axon; CF represents
synapses becoming fragmented after nerve section, but with at least one fragmented
still connected with an intact axon; DF represents both axons and synapses becoming
fragmented following axotomy; V represents both axons and synapses degenerating
completely after nerve section. Using PDD analysis, the diameters of circles
positioned at the apices of polyhedra representing their states, were set by the
proportions of neuromuscular junctions in each category. Blue circles represent the
fully occupied (O) state, red circles represent the disconnected fragemented (DF)
state, pink circles represent connected partial (CP) state, green circle represents the
connected fragmented (CF) state, and yellow circles represent vacant (V) state. I
used these diagrams to infer the most likely trajectories between states. Altogether, I
identified five degeneration states (O, DF, CP, CF, V) during synaptic degeneration,
with 7 possible trajectories from fully occupied endplates to vacant endplates,
namely, 1) O^DF^V; 2) O^CP-^V; 3) 0-*CF->V; 4) 0->CP-»DF^V; 5)
O—>CP—>CF—»V; 6) O—>CF—>DF—>V; 7) 0->CP~>CF->DF->V (See CD Rom for
animation). There is no possible endplate degeneration pathway from O state to V
state directly in any type of axotomised Wlcf mice. In each type of mouse, synaptic
terminals theoretically could follow any of these trajectories to degenerate. However,
the PDD analysis suggests that, in heterozygous Wlcf mice (Fig 3.13), most synaptic
terminals became DF and very few were CP at different time points, and therefore it
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can be concluded that the majority of endplates follow the process (O—>DF—>V),
while a few endplates go through other processes (O-CP-DF—>V or O—>CP—>V). In
wild-type mice (Fig 3.14), the main process of synaptic degeneration was similar to
heterozygous Wlcf (O—»DF—>V) and few endplates go through the CP or CF states
before degenerating completely.
However, in the homozygous Wlcf mice (Fig 3.15), the degeneration patterns
are evidently different, most endplates go through CP state before degenerating
(O—>CP—>V), while very few endplates degenerate from O state to DF state
(O—>CF—>V or O—>CP—>CF—>-V). This suggests that synaptic terminals
progressively retract following axotomy in homozygous Wlcf mice but undergo
fragmentation and synchronous degeneration in wild-type mice. A single copy of the
Wlcf' gene (i.e. Wlcf heterozygous) is not sufficient to mitigate or convert the mode
of degeneration, from that of the wild type to that of homozygous type. Thus, the
pattern of synaptic degeneration in heterozygous Wlcf mice is more similar to
wild-type than to the slow retraction of motor nerve terminal degeneration observed
in homozygous Wlcf mice. However, from the PDD analysis, the rate of synaptic
degeneration in heterozygotes is slower than in wild-type mice. For example, at 17
hours, some endplates in heterozygous were still occupied in heterozygotes, while all
endplates in wild-type degenerated completely. Therefore PDD analysis provides the
main evidence that NMJs degeneration in heterozygous Wlcf mice is delayed
compared with wild-type mice.
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Although the PDD analysis suggests there were significant qualitative
differences in the pattern of synaptic degeneration in Wlct homozygotes compared
with heterozygotes or wild-type, alternative interpretation can not be ruled out at
present. For instance, the CP (and /or CF) states could be quite common but rapidly
transient in wild-type and heterozygotes. Such issues may only be unequivocally
resolved using techniques such as repeated visualization in vitro (e.g. Walsh &
Lichtman, 2003).
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Figure 3.1 Morphological Evidence for Different Degeneration Patterns
of Neuromuscular Junctions.
All NMJs are from lumbrical muscles of axotomised young CFP/WZd5 mice (2
month old) and stained for TRITC-a-bungarotoxin. Figures (A, B, C, D) show the
different percentage occupancy of endplates after axotomy using confocal
microscopy. (A) Confocal image showing vacant endplates (0%); (B, D, E) Confocal
images showing the partially occupied endplates, for example, 25% partially
occupied endplates (B); 50% partially occupied endplates (D); and 75% partially
occupied endplates (E); (C) Confogal image showing fully occupied endplates. This
analysis method of synaptic degeneration is also used in CFP and YFP16 Wl<f mice




Figure 3.2 Synapses Retract in Axotomised Wlcf Homozygotes
Standard confocal microscopy images of NMJs from young CFPIWltf mice (2
month old) deep lumbrical muscles (labelled with TRITC a-BTX). (A, B, C & D)
Scale bar = 30pm.
(A) Confocal images of NMJs from a CFP/Wlcf mouse at 3 days following
nerve section.
(B) Confocal images of NMJs from a CFP/Wlcf mouse at 5 days following
nerve section.
(C) Confocal images of NMJs from a CFP/Wlcf mouse at 7days following nerve
section.










Graphs showing the time course of synaptic degeneration in the deep lumbrical
muscles of CFPIWldt mice after 5, 7, and 9 days axotomy. (Graph A, B, C) Error
bars represent ±SEM
(A) Each column represents the percentage of total number of endplates in each
occupancy group in young Wlcf mice 5 days after axotomy.
(B) Each column represents the percentage of total number of endplates in each
occupancy group in young Wlcf mice 7 days after axotomy.
(C) Each column represents the percentage of total number of endplates in each





A.i i i i 1 1—1 1—






i 1 i i i i i i—










Figure 3.4 Morphological Evidence for Preservation of Axons
(A, B, C & D) Confocal micrograph of tibial nerves from three different types
of YFP16 transgenic mice (Heterozygous Wlct, Wild-type, Homozygous Wlct) at 4
days after unilateral sciatic nerve section. Note that some axons show some evidence
of vacuolation inclusions. The reasons for this are unknown but could be related to






Figure 3.5 Morphological Evidence for Preservation of Neuromuscular
Junctions
Confocal micrograph from 2 month YFP16 Wlcf/WlcF mice NMJs, 1 day or 3
days post axotomy. (labelled with TRITC a-BTX)
(A) Unoperated lumbrical muscles, showing fully occupied endplates and intact
axon.
(B) Heterozygous lumbrical muscles after 3 days, showing vacant endplates
(C) Wild-type lumbrical muscles after lday, showing vacant endplates
(D) Homozygous lumbrical muscles after 3 days, showing almost all endplates







Figure 3.6 Synaptic Degeneration in Young YFP16 Homozygous Wl<f
Mice after Axotomy
Quantitative analysis of synaptic degeneration in the axotomised NMJs from
YFP16 Wl(f/Wl(f mice. Bar charts show the percentage of vacant endplates at 3, 5, 7,
and 9 days post axotomy. Means and standard errors are shown.
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Figure 3.6
94
Figure 3.7 Complete Reconstruction of the Neuromuscular Innervation
in young YFP16/C57BI6 (wild-type) Lumbrical Muscles at 6 Hours after
nerve section
(A) Montage of confocal micrographs of YFP16 C57/B16 mice 6 hours after
axotomy, many nerve terminals (AChRs labeled red) are occupied by intact
YFP16-labeled axons (green). Scale bar=200pm




Figure 3.8 Reconstruction of Neuromuscular innervation in Lumbrical
Muscles of Young Heterozygous Wlcf Mice (2 months old) at 12 hours
after nerve section
Montage showing 40 times objective confocal micrograph of YFP16
Balbc/WZ^ mouse lumbrical muscles 12 hours after axotomy, Most endplates
(AChRs labeled red) remain occupied, and YFP16-labeled axons (green) and nerve




Figure 3.9 Reconstruction of the Neuromuscular Innervation in
Lumbrical Muscles of Young Heterozygous Wlcf Mice (2 months old) at
20 Hours after nerve section
(A) Montage of confocal micrographs of YFP16 Balbc/WW's mice 20 hours
after axotomy, neuromuscular junctions (AChRs labeled red) and YFP16-labeled
axons (green) degenerate. Scale bar=200pm (Fig B&C). Confocal image showing
different degeneration patterns of nerve terminals and axons at higher magnification.
(B) Confocal image showing fully occupied endplate (white arrow) and vacant




Figure 3.10 Reconstruction of the Neuromuscular innervation in the
Lumbrical Muscles of Young Heterozygous Wlcf mice 4 days after
axotomy
Montage showing 40 times objective confocal micrograph of cross-bred Balb/c
mice with YFP16 Wlcf mice 4 days after axotomy. Scale bar=200pm. Almost all the
motor nerve terminals have degenerated but sensory axons supplying to muscle
spindles remain preserved (arrows).
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Figure 3.11 Time Course of Nerve Terminal Degeneration in Different
Types of Mice after Axotomy
Graph of the various time courses of nerve terminal degeneration in 2 months
old heterozgyous, homozygous Wlcf mice and C57/B16 mice following unilateral
sciatic nerve section. The data show the percentage of vacant endplates in different
mice (see Fig 3.5) Black triangles represent data from 2 months old C57/B16 mice,
and black inverted triangle represents data from 2 months old homozygous Wlct mice.
White circle represents data from 2 months old heterozygous Wlct mice. A statistical


















Figure 3.12 Confocal Micrographs Illustrate the Five States of Axonal
and Synaptic Degeneration
O represents fully occupied endplates, at which the terminal is connected to
intact axons; CP represents partially occupied endplates which are connected with
intact axon; CF represents fragmented endplates at which at least one fragement is
connected with an intact axon; DF represents endplates with synaptic boutons
disconnected from axons, both axons and terminals are fragmented, that is, where
there was no discernable continuity between the axon and the motor nerve terminal.
V represents endplates where terminals and axons were both degenerated completely.
Two other possible states are a fully occupied endplate with the terminal
disconnected from its axon ("DO"); and a partially occupied endplate with the












Figure 3.13 PDD Analysis on Young Heterozygous Wl<f Mice
The PDD shows the states of axonal and synaptic degeneration in the young
heterozygous Wlct mice. All five states (O, DF, CP, CF, V) of synaptic degeneration
were found. Blue circles represent fully occupied endplates (O). Purple circles
represent partially occupied endplates connected with intact axons (CP). Green
circles represent fragmented endplates connected with intact axons (CF). Red circles
represent fragmented endplates disconnected from the axon (DF). Yellow circles
represent vacant endplates without axonal connection (V). Arrows represent the
possible trajectories of axonal and synaptic degeneration at different time points in
the young axotomised heterozygous Wlct mice.
The chart shows the percentages of different states of axons and synapses during
the degeneration process in axotomised heterozygous Wlct mice at 6-hours, 12-hours,
17-hours, 20-hours and 24-hours time points, and standard error estimates with every
percentage of endplates. Endplates degenerated dramatically between 12 hours and
17 hours post-axotomy.
The variable signs of the CF and CP states probably reflect individual variation











6 hours 12 hours 17 hours 20 hours 24 hours
O 85.2142.34 81.0242.60 15.4142.44 6.2841.39 11.6644.19
CP 1.64 1.7640.19
CF 7.4841.62 1.6640.35
DF 12.4441.79 12.85±2.89 57.2442.51 36.8646.38 32.1345.40
V 8.6242.63 13.0743.26 23.1943.78 63.7449.15 58.0145.25
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Figure 3.14 PDD Analysis on Young Wild-Type Mice
The PDD shows the states of axonal and synaptic degeneration in young wild-
type mice. All five states (O, DF, CP, CF, V) of synaptic degeneration were found.
Blue circles represent fully occupied endplates (O), Purple circles represent partially
occupied endplates connected with intact axons (CP). Green circles represent
fragmented endplates connected with intact axons (CF). Red circles represent
fragmented endplates disconnected from the axon (DF). Yellow circles represent
vacant endplates without axons connected (V). All arrows represent the possible
trajectories of axonal and synaptic degeneration at different time points in the
axotomised young wild-type mice.
The chart shows the percentages of different states of axons and synapses during
the degeneration process in axotomised wild-type mice at 6-hours, 12-hours,
14.5-hours, and 17-hours time points, and standard error estimates with every
percentage.
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6 hours 12 hours 14.5 hours 17 hours
0 72.91±2.22 64.90±6.21 10.74±3.61 0
CP 0.49 0
CF 2.8±1.68 9.01±3.88 0.49 0
DF 25.69±2.43 32±7.09 85.34±4.25 0
V 3.25±0.94 2.29±0.26 12.151±6.55 0
no
Figure 3.15 PDD Analysis on Young Homozygous Wl<f Mice
The PDD shows the states of axonal and synaptic degeneration in homozygous
Wlcf mice. Four states (O, DF, CP, V) of synaptic degeneration were found. Blue
circles represent fully occupied endplates (O), Purple circles represent partially
occupied endplates connected with intact axons (CP). Red circles represent
fragmented endplates disconnected with axon (DF). Yellow circles represent vacant
endplates without axons connection (V). All arrows represent the possible trajectories
of axonal and synaptic degeneration at different time points in the axotomised
homozygous Wlcf mice.
The chart shows the percentages of different states of axons and synapses during
the degeneration process in homozygous Wlcf mice following at 3 days, 5 days, 7
days and 9 days following axotomy, and standard error estimate with every
percentage of endplates.
In this sample, almost 10% of endplates were vacant only 3 days after axotomy,
whereas previous data suggest that all endplates were occupied up to almost 4 days
after axotomy. The difference could be explained perhaps either by sample variation,
or perhaps the more detailed analysis performed here gives a more accurate






3 days 5 days 7 days 9 days
O 61.28±4.95 29.07±4.47 9.17±1.84 4.62±0.85
CP 19.00±2.57 40.87±1.98 28.81±2.96 15.36±2.04
CF 1.82±0.33 0.90±0.15
DF 5.49±2.28 2.30±0.38 3.85±0.78 5.02±0.76
V 10.78±4.04 28.32±5.78 59.32±3.85 75.53±2.38
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Summary
Previous studies have shown that the degeneration of axons and synaptic
terminals is much delayed by the Wlcf gene in the mutant Wlcf mice, in contrast to
wild type mice. Moreover, Mack et al (2001) have shown that axon degeneration is
gene dose-dependent in Wlcf transgenic mice. Therefore, the main effort in this
chapter was focused on measuring the Wlcf gene effect on synaptic terminal
degeneration within wild type, heterozygous, and homozygous Wlcf mice. (The Wlct
gene dose is only half in heterozygous Wlcf mice,). There are three main findings in
this chapter.
First, synapses are more sensitive than axons to the Wlcf gene than axons. In
heterozygous Wlcf mice (Figure 3.2 & 3.4), I showed that axons remained intact in
heterozygous Wlcf mice as well as in young homozygous Wlcf mice following nerve
section. Flowever, the data demonstrated that synapse degeneration in heterozyougs
Wlcf mice was although slightly slower than wild type mice, was faster than in
young homozygous Wlcf mice.
Second, the morphology of synaptic degeneration in these different types of
mice, as measured by both immunocytochemical staining and fluorescent protein
expression, showed that the synaptic degeneration pattern in heterozygous Wlcf mice
was distinct from that in young homozygous Wlcf mice, and more similar to that in
wild type mice. That is, the majority of synaptic degeneration in the axotomised
heterozygous Wlcf mice was more like the Wallerian degeneration process in wild
type mice. However, axons still remain intact.
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Third, PDD analysis revealed distinct difference in the patterns of synapse
degeneration in wild-type mice, young heterozygous, and young homozygous Wlcf
mice. The analysis implied the possible trajectories in wild-type mice, young
homozygous and heterozygous Wlcf mice. In homozygous Wlcf mice, the main
process appear to be O—»CP—>V, and a few endplates go through O—>CF—>V or
O—>CP—>CF—>V. In heterozygous WW mice, the main process is O—>DF—>V, and a
few endplates go through O—>CP—»DF—>V or O—»CP—>V trajectories. Finally, in
wild-type mice, additional to processes similar to those in heterozygous Wlcf mice,
other processes that a few endplates go through are O—>CP—>CF—>V; O—>CF—>V;
O—►CP—►DF—>V; O—>CP—>CF—»DF—»V. It is unlikely that the difference could be
explained by difference in the time intervals between samples. If that were the case,
the slow rate of degeneration in homozygous Wlcf mice should also have enabled
visualization of those other states as well.
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4. Analysis of Synaptic Degeneration in
Old Wlcf Mice and W!<f Protein Expression
in Cerebellar Granule Cells
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4.1 Introduction
The previous chapter showed that nerve terminals are progressively withdrawn
from axotomised endplates in young Wlf mice. In more mature mice (age >7
months old), this synaptic degeneration pattern is absent, although axons are still
protected from axotomy (Gillingwater et al., 2002). That is, in older mice, motor
nerve terminals appear to degenerate almost as rapidly as in wild-type mice.
Classical degenerative signs appear in most synaptic terminals after axotomy, such
as swollen and disrupted mitochondria, reduced synaptic vesicle densities,
intra-terminal membrane whorls, fragmented terminal membranes and terminal
Schwann cell phagocytosis.
In chapter 3,1 showed that synaptic protection is weak when the Wlf gene dose
is halved. Thus a plausible hypothesis to account for the loss of synaptic protection
with age in Wlf mice, is that expression of the protective Wlds protein declines with
age. However, in previous work, levels of expression of the chimeric protein as
indicated by western blotting of homozygous Wlf mouse brain tissue, suggested that
Wlds protein expression did not diminish significantly with age (Gillingwater et al.,
2002).
In this chapter, I examined the time course of axotomy-induced synaptic
degeneration in old Wlf mice. I utilised the same PDD analysis to depict the pattern
of degeneration in old homozygous Wlf mice as that which was used in wild-type
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and young heterozygous and homozygous Wlcf mice (see Chapter 3). In order to
evaluate whether the morphology of synaptic degeneration could be due to a change
in Wlds protein expression level in young homozygous and heterozygous and old
homozygous Wlcf mice, I used quantitative immunocytochemistry to measure Wlds
protein expression in cerebellar granule cells, stained with Wld18 antibody. It is
debatable whether immunocytochemistry is a better or more reliable method for
quanlifying protein expression. However, inmmuocytochemistry certainly provides
better optical resolution (at a cellular level) compared with, say, western blot
analysis.
4.2 Methods
The methods used in the majority of experiments within this chapter were
described in Chapter 2. The following section describes methods which are specific
to this chapter. Wlcf protein was labeled with TRITC-Secondary antibodies and
imaged with the HeNe laser and nuclei were counterstained using Topro 3 and
visualize using the red diode laser on the BioRad radiance 2000 confocal
microscope.
4.2.1 Wlds Protein Expression Analysis
Cerebellar slice images were obtained using confocal microscopy, images of
slice preparations were taken at two different channels at each laser power (HeNe
laser power 20%, 30%, 40%, 50%, 60% of maximum), because the nuclei were
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labeled by Topro-3 (red diode laser used to visualize Topro staining of nuclei) and
Wlcf genes were labeled by Wld18 ab, and then the two images were merged using
the integrated BioRad software to form an image of Wlds protein expression on
cerebellum granule cells. Pixel intensities were measured using the Image J
programme. First, images in the red channel were loaded in order of laser power
from the lowest to the highest laser power in the stack (20, 30, 40, 50, 60 etc).
Several Wlds protein spots were selected and the pixel intensity of each spot was
measured using the Image J programme, next, the same method was used to measure
background regions in each slice (i.e. regions between Topro-stained nuclei), the
corrected brightness of spots was obtained by subtracting background intensities
from each of them. Thirdly, the means and standard deviations of spot brightness at
each laser power were calculated. Lastly, a graph of laser power vs. corrected
brightness of spots was produced.
Similar techniques were attempted in the spinal cord. However technical
difficulties yielded unsuitable material for analysis. Thus I used cerebellum to test
the hypothesis instead.
4.3 Results
4.3.1 The Morphology of Neuromuscular Junctions in Old
Wlcf Mice
Confocal images of neuromuscular Junctions were taken from YFP16 Wlcf
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mice aged 7-12 months old, 3 days after unilateral sciatic nerve section. All muscles
were labeled with TRITC a- BTX, and fixed in 4% paraformadehyde. Unlike young
Wlcf mice, the pattern of endplate degeneration suggests that synapses were removed
more quickly in these old Wlcf mice. Figure 4.1 A shows three different patterns of
endplate innervation during degeneration (Blue arrow= fully occupied endplate,
Purple arrow= vacant endplates, White arrow= fragmented endplates compared with
Fig 3.5 D). However, as in young Wlct mice, the axons of old Wlcf mice degenerated
slowly following axotomy (Fig 4.1 B), they appeared completely intact 3 days after
unilateral sciatic nerve section.
4.3.2 PDD analysis of axotomised NMJ in old Wlcf mice
I classified the states of innervation and occupancy of neuromuscular junctions
sampled in old Wlct mice (N= 6) to assess the patterns of synaptic degeneration. In
the previous chapter, I identified five different states of axonal and synaptic
degeneration in wild type, young heterozygous, and homozygous Wlcf mice during
axotomy, they are: O state which represents fully occupied endplates connected with
intact axons, CP state which represents partially occupied endplates connected with
intact axons. CF state which represents fragmented endplates connected with intact
axons. DF state which represents fragmented endplates with disconnected axons, and
V states which represents vacant endplates. There are 7 possible trajectories of
axonal and synaptic degeneration, namely 1) O—»DF—>V; 2) O—>CP—>V; 3)
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O—»CF—>V; 4) O—»CP—»DF—»V; 5) 0->CP-+CF^V; 6) O^CF^DF->V; and 7)
O—>CP—>CF—>DF—>V. Using this same classification, I found only four main
distinct states of axonal and synaptic degeneration in old axotomised Wlct mice.
They were: fully occupied (O), disconnected fragmented (DF), vacant (V), and very
few connected partial (CP) at 17 hours, 24 hours, and 48 hours post axotomy. More
specifically at 17 hours after axotomy, 78.72%±3.7 NMJs were fully occupied
endplates with intact axons. 16.60%±2.25 NMJs appeared fragmented both in axons
and synapses, and only 7.02%±0.88 NMJs had degenerated completely (Figure 4.2).
Therefore, taking all data together, I conclude that the main trajectory of synaptic
degeneration is O—>DF—>V, and few synapses also go through O—>CP—>DF—>V or
O—>CP—>V trajectories. This pattern is remarkably similar to that observed in young
heterozygous Wlct mice and completely different from that observed in young
homozygotes. However the synaptic degeneration in axotomised old Wlct mice is
slower than heterozygous Wlcf mice.
4.3.3 Protein Expression in the Cerebellum of Wlcf Mice
Cerebellar slices were taken from three young (1-2 months) YFP16 Wlct mice,
three young YFP16 heterozygous Wlct mice, and three old (>8 month) YFP16 Wlct
mice. Wlds proteins in these slices were labeled immunocytochemically with the
Wld18 antibody. Figures 4.3 & 4.4 show the Wlds protein expression in cerebellar
granule cells (CGC) of young and old homozygous and young heterozygous Wlct
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mice. It appears from these images that in heterozygous Wlcf mice, fewer CGC
appeared to express Wlds protein (TRITC immunostaining, red) in their nuclei (blue;
Topro stain), compared to the young homozygous (2 month-old) Wlcf mice and old
(7 month-old) homozygous Wlcf mice. However, using progressively increasing
excitation laser power (HeNe laser power 20%, 30%, 40%, 50%, 60% of maximum)
number of cells with spots in their nuclei gradually increased (Figure 4.5 & 4.6).
These two groups of images were from a homozygous Wlcf mouse and a
heterozygous Wlcf mouse. In the heterozygotes, the amount of Wlds protein detected
was significantly greater with a laser power setting of 60% (Fig 4.5; 4.7D P<0.05,
ANOVA). This finding suggests that varying the excitation laser power is a useful
way to detect differences in Wlcf protein expression.
In this experiment, at the same laser power setting, Wlds protein expression
differed in young homozygous, heterozygous and old homozygous Wlcf mice. Wlds
protein seemed to be expressed in most cerebellar granule cells in Wlcf mice,
whereas the amount of Wlds protein was obviously reduced in the young
heterozygous Wlcf mice. However, in the old Wlcf mice, the Wlds proteins
expression was not consistent, the amount expressed in some of cerebellum granule
cells were more in some areas than in other areas (Fig 4.4), Indeed, at low laser
power, it did not seem that Wlds proteins were expressed in most of the cerebellum
granule cells as in young heterozygotes. In order to analyse the differences in Wlds
protein expression in young homozygous and old homozygous Wlcf mice, and young
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heterozygous Wlct mice, the mean intensity of proteins expressed in the CGC were
tested in the each type of mouse at varying laser powers (20%, 30%, 40%, 50%,
60%). Fig4.7, A, B, C shows that in each type of mice, the mean intensity of
immunofluorescence gradually increased with following the increasing laser powers.
Moreover, Wlds proteins showed stronger expression in young homozygous Wlct
mice than in young heterozygous and old homozygous Wlct mice. The increases in
mean intensity of Wlds proteins fluorescence in both heterozygous and old
homozygous Wlct mice were not as obvious as in young homozygous Wlct mice,
even though the mean intensity of Wlds protein in old Wlct mice was relatively
higher than in heterozygous Wlct mice. The difference was most apparent at 60%
laser power, figure 4.7, D shows the distinct mean intensity of each type of mouse at
60% laser power. A (young Wlct) = 9.907 ± 0.657, B (heterozygotes) = 5.1385 ±
0.6165, C (old Wlct) = 6.5957 ± 0.4517 (P<0.001; A vs B, P<0.01; A vs C, one-way
ANOVA, Dunnett's post hoc test). This analysis therefore suggests that mouse age
could be another intrinsic factor affecting Wlds protein expression. The level of
protein expression in old heterozygous Wlct mice was not examined in the present
study. Wlct mice have a normal life span, thus the reason for the apparent selective
decline of Wlds protein examination in some neurons is also unknown but potentially
of great interest for future research.
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Figure 4.1 Morphology of NMJs of Old WIcfMice after Axotomy
(A) Confocal image of NMJs from an Old YFP16 Wlct mouse 3 days after
axotomy. Postsynaptic terminals stained by a-BTX.
Three different colour arrows showing the various states of nerve terminals,
fully occupied endplates (blue arrow) fragmented endplates (white arrow) and vacant
endplates (pink arrow). Scale bar = 30pm.
(B) Confocal image of axons from an old YFP16 Wlct mouse 2 days after
unilateral sciatic nerve section. Scale bar = 30pm.
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Figure 4.2 Polyhedral Degeneration Diagram (PDD) Analysis of Synaptic
Degeneration in Old Wl<f Mice
The PDDs show the process of axonal and synaptic degeneration in the
axotomised old (>8 months) Wlcf mice. Letters are used to represent the states of
axons and synapses during neuronal degeneration after axotomy. That is, O
represents fully occupied endplate; connected with intact axons, CP represents
partially occupied endplate which is connected to an intact axon; CF represents
fragmented endplate that is connected to intact axons; DF represents terminal
disconnected from axons, where both of them are fragmented, V represents that
endplates and axons are both degenerated completely. Blue circles represent the fully
occupied (O) state, red circles represent the disconnected fragmented (DF) state,
pink circles represent connected partial (CP) state, and yellow circles represent
vacant (V) state.
The chart shows the percentages of different states of axons and synapses
during the degeneration process in axotomised old (> 8 months) Wld5 mice at
17-hours, 24-hours and 48-hours time points, and standard error estimates with every
percentage of endplates.
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17 hours 24 hours 48 hours
0 78.72±3.70 54.432±8.25 16.43±3.62
CP 4.65±2.22 4.95±1.95 2.324±0.36
CF
DF 16.60±2.25 32.84±3.93 44.82±4.23
V 7.02±0.88 12.41±3.60 37.34±5.14
126
Figure 4.3 Protein Expression in the Cerebellar Granule Cells (CGC) of
Wlcf mice
(A-B) Confocal images of cerebellar granule cells from the Wlcf mice at zoom
2.5. Wlds protein immunostained with Wld18 (red), and nuclei stained with Topro-3.
Scale bar = 5pm
(A) Cerebellar granule cells from a 2 months old homozygous Wlcf mouse





Figure 4.4 Protein Expression in the Cerebellar Granule Cells (CGC) of
Old Wlcf Mice
(A-B) Confocal images of cerebellar granule cells from old Wlcf mice at zoom
5.0. Wlds protein immunostained with Wld18 (red), and the nuclei stained with
Topro-3 (blue). Different regions of the cerebellum appear to show different levels of




Figure 4.5 Wl<f Protein Expression in Different Laser Powers in
Heterozygous and Young Homozygous Wl<f mice
(A-B) Confocal images of cerebellar granule cells from young heterozygous &
homozygous Wlct mice (8 weeks old) with increasing laser power (HeNe laserpower
20%, 30%, 40%, 50%, 60% of maximum). The nuclei of cerebellar granule cells
immunostained with Topro-3 (blue) and Wlct proteins immunostained with Wld18












Figure 4.6 Wlcf Protein fluorescence at Different Laser Powers in Old
Wlcf Mice
(A) Confocal images of cerebellar granule cells from Old Wlcf mice (>7 months
old) with increasing laser power (HeNe laserpower 20%, 30%, 40%, 50%, 60% of
maximum). The nuclei of cerebellar granule cells immunostained with Topro-3 (blue)











Figure 4.7 Intensity of Wlds Protein Expression in Heterozygous Wlcf
and Homozygous Wlcf Mice
(A) Graph of laser power versus mean spot intensity in 2 month-old Wlcf mice
as calculated from counts of immunocytochemically stained (Topro-3, Wld18
antibody) cerebellar granule cells. Black squares represent data from three 2 months
old homozygous Wlcf mice.
(B) Graph of laser power versus mean spot intensity in 2 months old
heterozygous Wlcf mice as calculated by counts of immunocytochemically stained
1 8
(Topro-3, Wld antibody) cerebellar granule cells. Squares represent data from three
2 month-old Wlcf heterozygous mice.
(C) Graph of laser power versus mean spots intensity in 7 months old Wlcf mice
1 8
as calculated by counts of immunocytochemically stained (Topro-3, Wld antibody)
cerebellar granule cells. Black squares represent data from three 7 month-old Wlcf
mice.
(D) Mean intensity of Wlds protein in young homozygous and heterozygous
Wlcf mice, and old homozygous Wlcf mice respectively at 60% laser power, column
A represents young Wlcf mice; column B represents young heterozygous Wlcf mice;
column C represents old homozygous Wcf mice (ANOVA test: P<0.0001; A vs B,
P<0.01; A vs C, P<0.01; Dunnett's post hoc test).
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In the previous chapter, I showed that the Wlcf gene plays an important role in
delaying the degeneration in axons and synaptic terminals. Moreover, gene dose, a
genetic intrinsic factor, influences the degeneration pattern of axons and synapses in
the axotomised Wlcf mice.
Age is another intrinsic factor affecting nerve terminal degeneration, and has
been presented by Gillingwater et al (2002). They showed that when mice were over
4 months old, synaptic degeneration reverted back to a Wallerian-like process, but
with axons still intact. The PDD analysis method I applied to old Wlcf mice extends
their findings (Figure 4.2). Wlds protein expression in the cerebellar granule cells in
young heterozygous Wlcf mice and old homozygous Wlcf mice suggested that Wlcf
protein expression is decreased in many neurons of the axotomy-induced old Wlcf
mice, in contrast to the young axotomised homozygous Wlcf mice.
Therefore, reduced protein expression in old Wlcf mice may explain the distinct
axon and synaptic protection as old Wlcf mice age, at least in some neurons.
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5. Effect of Botulinum Toxin and Nerve




Botulinum toxin is a neurotoxic protein produced by the bacterium Clostridium
botulinum. It is one of the most poisonous naturally occuring substances known. Its
highly toxic property has been used in minute doses to treat many nervous system
diseases: muscle spasms, uncontrolled blinking, headache disorders and
musculoskeletal pain (Bhidayasiri et al., 2005). It even improves sialorrhoea in
Amyotrophic Lateral Sclerosis (ALS) (Giess et al., 2002), however, recently the
most popular use of botulinum toxin (BoTox) in many parts of the world has become
in the field of cosmetic treatment. For instance, de-wrinkling properties are due to its
action as muscle relaxant. BoTox also promote nerve sprouting as well as inhibitory
Ca2+influx into motor nerve terminals during activities. It was therefore of interest to
ask whether it might delay synaptic degeneration as well.
Botulinum toxin is a two-chain polypeptide which contains a 100-kDa chain
and a 50-kDa light chain joined by a disulphide bond. The light chain is a protease
whose action prevents vesicles from anchoring to the nerve terminal membrane to
release acetylcholine, This action is mediated by one of the fusion proteins targeted
by BoTox (see below) at a neuromuscular junction. The toxin must enter the nerve
terminals in order to cause paralysis. This requirement is mediated by the heavy
chain of the toxin which targets the toxin to specific types of axonal terminals.
After attachment of the toxin heavy chain onto proteins on the surface of nerve
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terminals, the entire molecule is taken up into neurons by endocytosis. The light
chain which has the protease activity, leaves endocytotic vesicles and enters the
cytoplasm. Botulinum neurotoxin type A (BoTox/A) blocks the exocytosis of
acetylcholine (Ach) by its intracelluar proteolytic cleavage of
synaptosomal-associated protein, with a molecular mass of 25 kDa (SNAP-25), a
vesicular type of SNARE protein (Schiavo et al., 1993; Blasi, 1993). Interestingly,
botulinum neurotoxin type A also stimulates sprouting of nerve endings at the
neuromuscular junction after blocking neurotransmission (de Paiva et al; 1999). The
process takes a few days and appears to be a consequence of muscle paralysis
(Brown et al., 1977; 1980; 1982; Caroni et al., 1994).
Neither the mechanism of synaptic degeneration nor regulation has been fully
clarified, finding compounds that slow down synaptic degeneration is another
objective of neurodegenerative disease research. Botulinum toxin A was used to test
whether blocking transmitter release could protect synaptic terminals from
degeneration after axotomy.
Nerve Stump Length
Miledi & Slater (1970) used rats to test the effect of nerve stump length on
synaptic degeneration by cutting a short stump and a long stump of phrenic nerve.
They examined synaptic transmission using electrophysiology and ultrastructural
techniques up to 48 hours later. They showed that the rate of synaptic degeneration
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varied with the different lengths of nerve stump. This finding confirmed previous
studies by Luco & Eyzaguirre (1955) on the tenuissimus of a cat. Moreover, in 1995,
Ribchester et al used Wlct mice to study the effect of nerve stump length on synaptic
degeneration. The results suggested that an increase of 1cm in the length of the distal
stump delayed degeneration by about 1-2 days. However, this conclusion was drawn
from physiological analysis, I therefore repeated these experiments using
morphological analysis to examine the outcome.
5.2 Method
Chronologically, the experiments described in this chapter were carried out
before colonies of Thyl.2 YFP mice became established. Hence, immunostaining of
axons and endplates was used to visualize the neuronal processes. Six young female
Wlcf mice (2 months old) were used in the experiments. 5pl botulinum toxin type A
(from Sigma) was injected into one hind foot of each of 3 mice before cutting the
sciatic nerve in the mid-thigh region. Each injection contained 1.0-1.5 ng BoTox. As
a control, the hind feet on the contralateral side of three other Wl<£ mice were
injected with 3-5 pi of the non-sprouting buffer only1 (for composition see
Appendix I) Similar injections were made in three WlcF mice in which the tibial
nerve was cut instead of the sciatic nerve (Distance between sciatic and tibial nerve
lesion sites was almost 2 cm). Five days after axotomy, the animals were killed, the
1 Conventional physiology saline buffer is reported to produce a small amount of
sprouting (W. Thompson, personal communication to R.R Ribchester).
"
Non-sprouting" buffer has composition that avoids this.
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tibial nerve was stimulated with 10V, 1ms pulses. Absence of contraction confirmed
neuromuscular paralysis on the injected side. The lumbrical muscles were isolated
and stained with the TRITC a- Bungatrotoxin, and immunostained with NF and SV2.
The images were viewed and analysed by conventional fluorescence microscopy.
In addition, three old Wlcf mice (7 months old) with unilateral section of the
sciatic nerve were studied. Each operated foot of the three mice was injected with
3pl BoTox (c=0.05 ng/pl), (since I found that the old mice did not survive when
injected with the same volume of BoTox as in young mice) and the contralateral leg
injected with 3pl non-sprouting buffer as the sham control. Lumbrical muscles were
isolated from two of the mice 3 days after axotomy. Lumbrical muscles were isolated
from the third mouse 7 days after axotomy. Immunostained preparations were
viewed and analysed by fluorescence microscopy.
5.3 Results
5.3.1 Morphologic Evidence for Preservation of Synaptic
Terminals in Wlcf Mice after BoTox Injection in young Wlcf
mice
Lumbrical muscles 1, 2, 3, 4 (n=16) from 5 days axotomised 2 months old Wlcf
mice (n=6) were immunocytomchemically labeled (NF, SV2 and a- BTX).
Quantitative analysis suggests that BoTox had a small additive effect on the
protection from synaptic degeneration (Figure 5.1). The occupancy of NMJs gave
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the simplest measure of any effect. In BoTox injected muscles occupancy was
92.76%±1.4, while the occupancy of NMJs without BoTox injection was
80.038%±7.826 (P< 0.05, Mann-Whitney test). It was significantly different from
muscles injection with non-sprouting buffer solution
5.3.2 Botox has no Effect on Synaptic Degeneration in Old
Wcf Mice
Lumbrical muscles 1, 2, 3, 4 (n=12) from 3 days (N=2) and 7 days (N=l)
axotomised 7 months old Wlct mice (n=6) were immunocytomchemically labeled
(NF, SV2 and a- BTX) and the NMJs individually assessed as to their level of
occupancy. Qualitative analysis of lumbrical muscles preparations showed that
BoTox had little effect on the protection of synaptic degeneration (Figure 5.2).
Almost all endplates were vacant by 3 days, the percentage of vacant endplates after
BoTox injection was 88.48%±4.356 at this time, and increased to 98.87%±0.603 by
7 days after axotomy. This was not significantly different from control muscles,
injected with non-sprouting buffer solution. (Percentage vacancy data was plotted
here rather than percentage occupancy simply to facilitate visual comparison of the
data.
5.3.3 Morphologic Evidence for Preservation of Synaptic
Terminals in the Wld5 Mice after Axotomy: Effect of Nerve
Stump Length
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Lumbrical muscles 1, 2, 3, 4 (n=16) from 5 days axotomised 2 months old Wlcf
mice (n=6) were immunocytomchemically labeled (NF, SV2 and a- BTX) and the
NMJs individually assessed as to their level of occupancy.
Qualitative analysis of lumbrical muscle preparations suggests that nerve
terminals degenerated slightly slower in the sciatic nerve-cut compared to the tibial
nerve-cut groups. (Figure 5.3) However, quantitative analysis indicated that the
difference was not statistically different. The occupancy of endplates after axotomy
was 84.196% ±15.77, while the occupancy after tibial axotomy was 80.038% ±
17.50 (P>0.05; Mann-Whitney test).
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Fig 5.1 BoTox Effects on Synaptic Degeneration
(A) Conventional fluorescence microscopy images of NMJs from young Wlcf
mice (8 weeks old) with BoTox injection (immunostained with NF and SV2
antibodies and ACh receptors labelled with TRITC a-BTX). Scale bar = 30pm.
(B) Bar chart showing the percentage occupancy of endplates stained by a-BTX
in the lumbrical muscles 5 days after axotomy, from 2 months old Wlcf mice which
were injected with BoTox after sciatic or tibial nerve axotomy.
There was a small statistically significant additional delay in nerve terminal















Fig 5.2 BoTox Effect on the Old Wltf Mice after Axotomy
(A) Conventional fluorescence microscopy image of NMJs from old Wlcf mice
(>7 months old) with BoTox injection (immunostained with NF and SV2 antibodies
and labelled with TRITC a-BTX). Scale bar = 30pm.
(B) Bar chart showing the percentage of nerve terminals stained by a-BTX in
the lumbrical muscles 3 and 7 days after axotomy, from 7 months old Wlcf mice
which were injected with Botox after sciatic and tibial nerve axotomy. A few
endplates remained occupied 3 days after injection, but almost all nerve terminals





Fig 5.3 Nerve stump length experiment
(A) Bar chart showing the percentage of occupied endplates in the lumbrical
muscles 5 days after axotomy, from 2 months old Wlcf mice, injected with
non-sprouting buffer solution after sciatic and tibial nerve axotomy. The AChRs in
the postsynaptic membranes were stained by TRITC-a-BTX. The protection of







Wlct gene dose and age of mice influence the patterns and rate of axons and
synaptic degeneration after axotomy in Wlct mice. It was interesting to ask whether
extrinsic factors could also influence these processes, adding to the protective Wlct
phenotype. Here, I examined two potential influences that have been shown
previously to influence synaptic form and function in wild-type mice, namely muscle
paralysis and nerve stump length.
Although, previous studies suggested that blocking vesicle release may delay
degeneration of synapses (Mattison, 1999, PhD Thesis University of Edinburgh) in
my studies the degeneration of synaptic terminals was only slightly delayed
following BoTox injection in young Wlct mice 5 days after axotomy. Moreover, this
protective effect on synaptic terminals was lost in old Wlct mice 3 days after
axotomy, in these mice all terminals had degenerated either in the presence or
absence of BoTox. The different nerve stump lengths between sciatic nerve section
and tibial nerve section did not yield a significant difference in synaptic
degeneration.
These largely negative findings underscore the potency of the protective effect





The main findings of the present study are threefold: Firstly, synaptic protection
by Wlcf gene is more sensitive to reduced gene dose and mice age than axons or
synapses in axotomised young homozygous Wlcf mice. This finding is supported by
PDD analysis, which provides a new way of systematically and comprehensively
representing their pattern and "trajectory" of axonal and synaptic degeneration in
axotomy-induced wild type, young homozygous, young heterozygous and old
homozygous Wlcf mice. Using PDD analysis, we can see how similar patterns of
synaptic terminal degeneration occur in both young axotomised heterozygous and
old homozygous Wlcf mice, and this was distinctly different from the way synapses
degenerate in young homozygous Wlcf mice.
Next, I presented evidence that variation of synaptic degeneration in
heterozygous Wlcf mice may be due to its reduced expression of Wlds protein with
age in some neurons, suggesting that synaptic degeneration in old axotomised Wlcf
mice may also be modulated by a gene-dose effect. I measured Wlds protein
expression in cerebellar granule cells of young homozygous and heterozygous and
old homozygous Wlcf mice. I found a reduction of Wlds protein expression in all
neurons of young heterozygous mice and in at least some neurons in old homozygous
Wlcf mice. This decrease may therefore explain the distinct pattern of synaptic
degeneration in old Wlcf mice.
Thirdly, besides gene-dose and age, I examined the effect of two other potential
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influences: nerve stump length and neuromuscular transmission. However, I did not
find any compelling evidence that these significantly affect the rate of synaptic
degeneration. The results of leaving a long nerve stump did not confer any additional
protection, and blocking neuromuscular transmission with Botox only slightly
enhanced synaptic protection in young Wlcf mice, whilst there was no effective
protection in old (7 months old) Wlcf mice
6.1 The Wlcf Gene Strongly Protects Axons
In wild-type mice, Wallerian degeneration is normally complete within 24 to 48
hours of axotomy, the primary event in Wallerian degeneration is axonal
fragmentation and degeneration, which is accompanied by a failure of the nerve to
conduct in mice, at 1 to 2 days axotomy, the sciatic nerve becomes incapable of
conducting compound action potentials. (Vial, 1958; McDoald, 1972; Allt, 1976;
Nicholls et al., 1992)
In contrast, in the mutant Wlcf mice, the lesioned axon is preserved for several
weeks before eventually degenerating (Lunn et al., 1989; Tsao et al., 1994). In other
words, the Wlcf mutant has about a 10-fold delay in axonal degeneration after nerve
injury (Gillingwater et al., 2003). Furthermore, Mack et al 2001 suggested that axons
were still protected well in heterozygous Wlcf mice after axotomy, in despite of the
reduced gene dose. They used different lines of transgenic mice after the same
axotomy to demonstrate that axonal protection is gene dose -dependent. Their result
161
showed that axonal preservation in the transgenic line 4836Tg/+ (81.7 ± 2.2; n=3) is
similar to the Wlcf/+ (86.2±1.2; n=3) and Wlcf/Wlcf (90.0±4.7; n=3) at the same time
after axotomy, by observing that the transgene expression level in line 4836 is similar
to that in Wlcf/Wlcf mice. Subsequently, Gillingwater et al (2002) demonstrated that
axons were also preserved by the Wlcf gene in mature Wlcf mice (> 4 months old).
The findings of the present study on axon degeneration in these four different
types of mice have confirmed these previous studies. Confocal micrographs of tibial
nerves following sciatic nerve lesions have shown that in unilateral sciatic nerve
section, there was no obvious difference in axonal degeneration among young
heterozygous Wlcf, homozygous Wlcf, and old homozygous Wlcf mice, but in wild
type mice, the axons totally degenerated within the same period post axotomy.
(Figure 3.4 B, C, D & Figure 4.1 B). However, in further time course studies on
NMJs among young heterozygous, homozygous and old homozygous Wlcf mice, this
intramuscular axonal protection by the Wlcf gene following nerve section appeared
somewhat different. Further analysis of this will be discussed in the following PDD
analysis section.
6.2 NMJs are Very Sensitive to Gene Dose
In Mack et al's work, most studies focused on whether a change in Wlcf gene
dose affects axonal degeneration. As I pointed out in the Introduction comparing
homozygous and heterozygous Wlcf mice, provides a simple way to testing the effect
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of gene dose. Regarding the Wlds protein effect on synaptic degeneration, Mack et al
(2001) only mentioned that in transgenic heterozygous Wlct mice after 3 days, some
synaptic terminals were still occupied (Mack et al., 2001). Through morphological
and ultrastructural studies, Gillingwater et al (2002) suggested that age is another
factor which influences the synaptic degeneration. Consequently, the present study
was mainly focused on the synaptic degeneration as affected by both Wlct gene dose
and age in different types of mice following axotomy.
There are two copies of the chimeric Wlct gene in heterozygous Wlct mice and 4
copies in homozygotes. Young wild type mice, heterozygous and homozygous Wlct
mice were used to form a sample group with varying Wlct gene dose in the study.
Moreover, in order to investigate further the relationships of synaptic degeneration
among these types, the time courses of synaptic degeneration were studied in young
YFP16 homozygous andYFP16 heterozygous Wlct mice, and in YFP16 wild type
(C57/B16) mice, following the unilateral sciatic nerve section.
6.2.1 Wild-Type Mice
It has been shown that, in wild type mice, nerve terminals normally degenerate
within 24-26 hours, which is earlier than their motor axons (Birks et al. 1960; Miledi
& Slater 1970; Gillingwater et al., 2001). The process of synaptic degeneration is
synchronous in axotomised wild-type mice, both axons and synaptic terminals
degenerate rapidly following axotomy (Miledi and Slater, 1968; 1970; Winlow and
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Usherwood, 1975). In my present experiments, in YFP16 wild type mice, nerve
terminals began to degenerate rapidly and apparently simultaneously (i.e. more
synchronously than in homozygous Wlct mice) from 6 hours post axotomy and no
synaptic terminals were occupied at exactly 17 hours post axotomy. This is much less
than the 24-26 hours in previous work, and in total six YFP16 Wlct mice (8 weeks)
were used. My data and other evidence from studying rats and mice suggest that
degeneration of synaptic terminal precedes axon degeneration (Miledi and Slater,
1970; Beirowski et al., 2003). That is, axon fragmentation does not normally begin
until about 36 hours in peripheral nerves, whereas nerve terminals degeneration was
complete in my study by 17 hours.
6.2.2 Young Homozygous Wlcf Mice
In mutant Wlct mice, Ribchester et al (1995) showed that Wlct NMJs are
preserved and able to release neurotransmitter and recycle synaptic vesicle
membrane for at least 3 days, and in some cases as long as 2 weeks, following nerve
section. Moreover, vital dye labeling, immunocytochemistry and electrophysiology
suggest that while nerve terminals degenerate synchronously in axotomised
wild-type mice, progressive piecemeal synapse withdrawal is induced by axotomy in
Wlcf mice. It was suggested that nerve terminals retract from the endplate, bouton by
bouton, to form a swelling bulb at the distal end of the axon, which is detached from
the endplate (Mattison, 1999; Gillingwater and Ribchester et al., 2001). This pattern
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of terminal withdrawal occurs in a similar fashion during synapse elimination, which
takes place in neonatal mammals to form the neuromuscular innervation pattern in
postnatal development (Sanes and Lichtman, 1999; Keller-Peck et al., 2001;
Gillingwater et al., 2002; 2003).
In young homozygous Wld6 mice, the present findings showed that synaptic
degeneration have an appearance similar to that in previous studies which used
FM1-43 to label nerve terminals (Parson et al., 1998; Ribchester et al, 1999). In
Fig3.3 (A, B, C) with increasing days post axotomy, fully occupied endplates became
partially occupied endplates and eventually became vacant, the different percentage
patterns of partially occupied endplates at different times have suggested that the
axotomy-induced synaptic elimination in Wltf mice is a gradual withdrawal process
in Wltf mice. These data strongly support previous finding of a progressive
withdrawal pattern of synaptic degeneration in axotomised homozygous Wltf mice.
Thus the hallmark of homozygous Wltf mice is piecemeal, asynchronously and slow
synaptic retraction; whereas in heterozygotes or wild-type mice it is rapid, uniform
and much more synchronous. These differences suggest that the mechanisms are
different.
During the time course of studying synaptic terminal degeneration in young
homozygous Wltf mice, two different staining methods were used, one used CFP
transgenic mice and another Thyl-Y¥P\6 transgenic mice, since the Cyan and
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Yellow Fluorescence Protein in these lines express fluorochrome in all motor
neurons (Feng et al, 2000). The latter method is widely used in many recent NMJ
experiments, due to its accurate and good quality staining, so it was also used in the
majority of my studies. However, compared with CFP and YFP16 mice synaptic
degeneration data (Fig3.6) suggest there are differences in % vacant endplates in the
young Wlcf mice after the equivalent number of days post axotomy. The reason for
this difference is two-fold. Firstly, the first group of mice underwent tibial nerve
section, while the second group of mice had sciatic nerve section. With regards to the
nerve stump dependence hypothesis, in the sciatic nerve section experiment, synaptic
degeneration was slightly slower than that in the tibial nerve section experiment.
However, in my morphological experiment, there is no significant difference
between the sciatic and tibial nerve section. Secondly, the different transgenic mice
lines used in these two groups could be another reason for this difference. However,
recent studies show no effect of fluorescence protein examined on the rate of


























Mann-Whitnev: P=0 49: NS
YFP Non-YFP
Days post axotomy
From Bridge et aI (2007) Neurobiology ofAging. In Press.
Figure 6.1 YFP does not interfere with Wlcf
From Bridge et al (2007) showing that the rate and amount of synaptic
degeneration measured electrophysiologically from end-plate potential recording
(upper traces) is not significantly different comparing Wlcf mice expressing the YFP
transgene with those that do not express this transgene (graph).
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6.2.3 Young Heterozygous Wlcf Mice
Mack et al (2001) demonstrated that the number of occupied endplates
decreased in the 4836 hemizygous transgenic mice, compared with those in the 4836
homozygous transgenic mice. The 4836 transgenic line expresses similar level of
Wlds protein to natural mutant Wlcf mice. The study of nerve terminal degeneration
in young heterozygous Wlcf mice therefore supports this previous finding, and also
suggested that the Wlcf gene does have a protection effect on synaptic degeneration
in the axotomised heterozygous Wlcf mice, compared to wild type mice, although the
effect is much less than that in young homozygous Wlcf mice.
The present study of heterozygous Wlcf mice provided evidence that the
protection of motor nerve terminals by the Wlcf gene was weaker and also more
sensitive to gene dose than axons. Few studies to date have studied nerve terminals
on naturally heterozygous Wlcf mice. Mack et al (2001) provided data to show that
synaptic degeneration in transgenic heterozygous Wlcf mice is faster than that in the
transgenic homozygous Wlcf mice. The heterozygous Wlcf mice were produced by
crossed-breeding C5HWlds mice cross-breeding with Balbc/B16 mice. At one day
following unilateral sciatic nerve section, most endplates were vacant, while very
few were fully occupied. (Figure 3.13.B) Moreover, in comparison with the
homozygous Wlcf mice, the pattern of synaptic degeneration appeared to be distinct.
Neither piecemeal withdrawal of nerve terminals nor retraction boutons
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(Gillingwater et al., 2002) could be found during the degeneration process, and the
rate of degeneration of NMJs was faster than in the homozygous Wlct mice. Taking
these studies, it can be concluded that in heterozygous Wlct mice, the reduced dose
of the Wlct gene in a weak protection of synaptic degeneration.
6.2.4 Old Homozygous Wlcf Mice
The present experiment shows that only a few synaptic terminals could be found
after axotomy in old Wlct mice, most endplates were vacant, a few were fully
occupied, and very few were partially occupied. This finding confirms the previous
findings of Gillingwater et al (2002) who used the electrophysiology, vital staining
with FM1-43, immunocyto-chemistry and electron microscopy to demonstrate that
unlike axonal degeneration, the degeneration of synaptic terminals in Wlct mice is
age dependent. When mice are over 4 months old, the morphology of nerve terminal
degeneration reverts to that in wild-type mice. According to their morphological
analysis in old mice, very few partially occupied endplates were seen, and most
endplates were either fully occupied or vacant. In 4 months old Wlct mice about 35%
of endplates were occupied 3 days axotomy. In 7 months old Wlct mice, however,
fewer than 5% occupied endplates remained by 3 days. Electrophysiological analysis
suggested that in 4 month old mice, only approximately 20% of fibres showed EPPs
3 days following axotomy. In 7 months old mice less than 5% showed evoked EPPs.
The present results of morphological analysis in axons and synaptic degeneration
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also supported the group's findings, for example, in Wlct mice over 7 months old, <
20 % synaptic terminals were occupied at 2 days after axotomy (Figure 4.2), and due
to both intramuscular axons and synaptic terminals fragmenting, no EPPs could be
evoked when nerve fibres were stimulated.
6.3 Polyhedral Degeneration Diagram (PDD)
6.3.1 Pattern of Synaptic Degeneration
My studies suggest that there are at least two patterns of axons and nerve
terminals degeneration after axotomy in the wild-type mice and young Wlct mice.
That is to say, both axons and nerve terminals undergo classical Wallerian
degeneration in wild-type mice. In young Wlct mice, the synapses degenerate in a
retraction pattern similar to neonatal elimination (Gillingwater and Ribchester, 2003)
and axons are protected well by the Wlct gene in young Wlct mice.
However, when the time courses of synaptic degeneration in wild-type,
heterozygous and young and old homozygous Wlct mice were studied and the
degeneration of synaptic terminals further quantified different results were showed
by the present studies. The patterns of axonal and synaptic degeneration were more
complicated than the two mentioned above.
All states of innervation and occupancy of neuromuscular junctions were
classified into five patterns in young and old Wlct homozygous, heterozygous and
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wild-type mice to assess the patterns of axonal and synaptic degeneration. These
were occupied (O), connected/partial occupancy (CP), Connected/fragmented (CF),
Disconnected/fragmented (DF), Vacant (V) (See chapter 3 & chapter 4 for the
explanation for each state). We used these to infer the most likely trajectories
between states, including 7 possible degeneration trajectories of axonal and synaptic
degeneration, in wild type, heterozygous, and young and old homozygous Wlcf
following axotomy, such as, 1) O—>DF—>V; 2) O—>CP—>V; 3) O—»CF—>V;
4)0—>CP—»DF—>V; 5) O^CP^CF^V; 6) O^CF^DF^V; and 7)
O—>CP—>CF—>DF—>V; in wild-type, heterozygous, and young and old homozygous
Wlcf following axotomy. In all these trajectories, axons as well as synaptic
terminals take different tracks to degenerate from fully occupied endplates to various
states before degenerating completely. Apart from trajectory 2 (O—>CP—>V), which
has already been confirmed in young Wlcf mice, all trajectories remain merely
speculative. My hypothesis is that all of these are possible in the degeneration
process in axotomised mice; in reality, however, there may only be one, two or more
trajectories that exist. Based on time course data in young homozygous Wlcf mice,
CP state is the only state found during the degeneration process, therefore,
O—>CP—»V is the only one possible degeneration trajectory in axotomised
homozygous Wlcf mice.
Of course, the limitation of the PDD method is that it does not take into account
any variability in the denervation of each state which could also be a variable that
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explains the difference in the PDD trajectories. Nevertheless quantitative kinetic
analysis (e.g. Ribchester, 1988) may be necessary to resolve this issue.
My conclusion are consistent with the previous finding that synaptic
degeneration is a progressive withdrawal process in young axotomised homozygous
Wlcf mice, with presynaptic terminals gradually retracting from postsynaptic
terminals while the axons still entirely connect with them. However, in the young
axotomised heterozygous and wild-type mice, there were five states of axonal and
synaptic degeneration were found in the degeneration process, they are O (occupied),
V (vacant), CP(connected partial), CF(connected fragmented),and DF(disconnected
fragmented) respectively. Thus, it may be speculated that there were 7 possible
trajectories during the degeneration process, which are: 1) O—>DF—>V; 2)
O—>CP—>V; 3)0—>CF—>V; 4)O^CP-+DF^V; 5)0->CP-^CF^V;
6)0—*CF—»DF—>V; and 7)0—*CP—>CF—»DF—>V respectively. If fully occupied
endplates (O) started to degenerate following axotomy, they could go through any
one of CP, CF and DF states at the early degeneration stage. Then if fully occupied
endplates (O) went through the connected partial (CP) state first, there would be
three possible tracks for degeneration, firstly, CP—>CF—»V, where partially occupied
endplates become fragmented, with axons still entirely connected to fragmented
synaptic terminals, then the synaptic terminals disappear followed by the axons
breaking into small segments. A second pathway is CP—>DF—>V: the partially
occupied endplates degenerate into fragmented endplates and axons break into small
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segments before degenerating completely. The third is CP—>CF—>DF—>V: partially
occupied endplates become fragmented with axons still entirely connected to
synaptic terminals, axons then become fragmented followed by both synaptic
terminals and axons disappearing in the later degeneration stage.
If fully occupied endplates (O) went through CF at the early degeneration stage,
two possible following subsequent trajectories exist: One is CF—>V, where fully
occupied endplates become fragmented endplates following axotomy, with axons
still completely connected to endplates, then axons break in to small segments before
endplates degenerate completely, another trajectory is CF—dDF—>V; where partially
occupied endplates become fragmented followed by intact axons disconnecting, from
these fragmented endplates, and finally these axons break into small segments before
disappearing entirely.
Lastly, if fully occupied endplates (O) went through DF state at the early
degeneration stage, only one trajectory would happen, namely O—»DF—>V, in this
fully occupied endplates first become fragmented endplates, followed by axons
breaking into small segments in the early stage, and afterward both of them
degenerating completely in the later degeneration stage.
Analysis of PDD was used in the axonal and synaptic degeneration of the old
axotomised Wlct mice. There were four possible states at each time point, which are
fully occupied (O), disconnected fragmented (DF), connected partial (CP), and
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vacant (V). With increasing hours after axotomy, such as, at 17 hours and 24hours,
the majority of synaptic states were either fully occupied endplates connected to
axons (O) or fragmented endplates disconnected to axons, very few degeneration
pattern were partially occupied endplates connected to intact axons (CP).Therefore it
is speculated that there are three possible axonal and synaptic degeneration states in
old Wlct mice, most nerve terminals degenerate from fully occupied endplates to
disconnected fragmented endplates (O—>DF—>V), and very few endplates were
partially occupied before all nerve terminals degenerated completely
(O—>CP—»DF—>V or O—»CP—*V). PDD analysis of wild-type, young heterozygous,
homozygous and old homozygous Wlct mice provides a useful way to comprehend
the mechanism of NMJ degeneration following nerve section. From PDD, we
ascertained that the degeneration patterns of synaptic terminals were affected by
varying gene dose and mouse age. For instance, most synapses become fragmented
at each axotomised hours in young axotomised heterozygous Wlct mice, this
phenomena resembles Wallerian degeneration in wild type mice, and is different
from progressive asynchronous and piecemeal synaptic withdrawal in homozygous
Wlct mice.
From PDD analysis of these contrasting groups, it is possible to conclude that
reduced gene dose influences both degeneration pattern and degeneration rate of
synaptic terminals after axotomy. The Wallerian-like degeneration widely found in
axotomised heterozygous Wlct mice demonstrated that the pattern of synaptic
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degeneration reverted back to the wild type fashion. Electrophysiologically,
fragmented synapses can not evoke EPPs if axons are disconnected from these
synapses. Moreover, the rate of synaptic degeneration increases dramatically with
reduced gene dose, in contrast to young homozygous Wlcf mice.
In old homozygous Wlcf mice, two different states exist during degeneration,
the majority of synapses become fragmented (DF) after axotomy, and a few synapses
were in retracted fashion (CP), resembling synaptic degeneration in young
heterozygous Wlcf mice. Therefore, it could also be hypothesized that mouse age
plays a role in influencing Wlds protein expression, given the similarity of
morphological situations were found in the wild type, heterozygous and old
homozygous Wlcf mice.
6.3.2 Rate of Synaptic Degeneration
The rate, as well as pattern, of degeneration of nerve terminals is influenced by
gene dose and mouse age. For instance, the rate of synapse degeneration in both
axotomised young heterozygous and old homozygous Wldt mice was faster than in
young axotomised homozygous Wlcf mice. Moreover, some occupied endplates were
still found in young heterozygous Wlcf mice 1 day after axotomy and in old
homozygous Wlcf mice 2 days after axotomy, while in wild-type mice, synaptic
terminals degenerated completely at 17 hours post axotomy, in contrast, synaptic
degeneration can last nearly two weeks in young axotomised homozygous Wlcf
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mice.
6.3.3 Pattern and Rate of Axonal Degeneration
PDD analysis shows that the degeneration pattern and rate of proximal axons, as
well as synaptic terminals, are also influenced by gene dose and mouse age. The rate
of proximal axons degeneration was fast in axotomised heterozygous and old
homozygous Wlct mice, in comparison to homozygous Wlct mice. In wild-type mice,
since the majority of NMJs were in DF state following axtomy, it can be speculated
that the degeneration mechanism of axons which are connected to these synaptic
terminals is a Wallerian-like degeneration. This mechanism was also found in
axotomised heterozygous Wlct mice, where most intramuscular axons broke into
small segments either before or following synaptic terminals fragmentation (e.g. see
Fig 3.10). In contrast, no intramuscular axonal segments were found in homozygous
Wlct mice up to 3 days after axotomy, the pattern observed is similar to progressive
withdrawal following synapses retraction. However, in old homozygous Wlct mice,
these two different mechanisms may exist simultaneously during the proximal axon
degeneration process, given the DF state majority and a few CP states found
throughout this process. To date, as axonal mechanism still remains unclear in the
recent studies, thus, it is difficult to know whether the Wallerian-like degeneration of
intramuscular axons in both young heterozygous and old homozygous Wlct mice is
indeed similar to the mechanism in wild-type mice. This merits further investigation
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in future studies.
Beirowski et al (2005) suggested that different degeneration mechanisms of
distal axons occured in wild-type and Wlcf mice, thus, my present findings in
proximal axons may facilitate elucidation of the genuine mechanism of axonal
degeneration after nerve injury in the future.
In summary, PDD analysis suggests that the degeneration patterns of both axons
and synaptic terminals are influenced by both of Wlcf gene-dose level and mice of
age.
6.3.4 PDD Analysis in Neonates
Usage of PDD analysis is not restricted to the above type of mice, but may also
be extended to other types to study the time course of synaptic degeneration. For
instance, as an example, I applied PDD analysis to a study of neonatal elimination
(See PDD schematic picture below, the data from Keller-Peck et al 2001 Figure 6.2).
During synapse elimination in neonates, only the CP state is found, thus the pathway
O—>CP—>V alone may be speculated. Nerve terminals retract by a progressive
withdrawal process during synapse elimination, and axons are retracted after that
(Korneliussen and Jansen, 1976; Walsh and Lichtman, 2003). This result strongly
supports the previous findings that synapse elimination is a progressive withdrawal
process during innervation (Gillingwater & Ribchester, 2001; Gillingwater et al.,
2002).
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Furthermore this PDD could perhaps be applied to animal models or biopsy
material from patients with motor neuron diseases, such as Amyotrophic lateral
sclerosis (ALS) and used to measure the progression of diseases. By comparing with
Wlcf mice, it may be possible to uncover similar degeneration trajectories in NMJ, or
discover new patterns of axonal and synaptic degeneration in this disease model.
Greater knowledge of the mechanism of motor neuron degeneration may lead to
more effective treatments of motor neuron diseases. PDD is thus a potentially useful
analysis model in furthering our understanding of NMJ degeneration and advancing
motor neuron disease research in the future.
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Figure 6.2 Polyhedral Degeneration Diagram (PDD) Analysis the
Mechanism of Synaptic Degeneration Mechanism in neonates
The PDD shows the process of axonal and synaptic degeneration in the young
(8 days after birth) mice. Letters are used to represent the states of axons and
synapses during neuronal degeneration after axotomy. That is, O represents fully
occupied endplate; connected with intact axons, CP represents partially occupied
endplate which is connected to an intact axon; V represents that endplates and axons
are both degenerated completely.
The chart shows the percentages of different states of axons and synapses during
the degeneration process in young (8 days after birth) mice.
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6.4 Wlds Protein Expression in Cerebellar Granule Cells
As discussed in chapter 3 & 4, the Wallerian-like mechanism of synaptic
degeneration in heterozygous Wlf mice can be attributed to a decreased gene dose,
and similar degeneration pattern was also found in axotomised old Wlf mice.
The question remains whether the observed synaptic protection in old
homozygous Wlf mice and the similar mechanism of synaptic protection in young
heterozygous Wlcf mice may be accounted for by one single explanation. Could it be
all down to the age-dependence of Wlcf protein expression? Wlds protein is localized
to cell nuclei and is absent from neuronal cytoplasm, therefore Wlds protein localized
in the neuronal nuclei is sufficient to protect against PNS axonal degeneration, and
CNS synaptic degeneration from injury, and disease-induced neuro-degenerative
stimuli (Lunn et al., 1989; Gillingwater and Ribchester, 2001; Wang et al., 2001;
2002). Wlds protein expression was measured in cerebellar granule cells in order to
test this hypothesis, since cerebellar granule cells in the Wlf mouse have a consistent
and high level of expression of Wlds protein with about 90% of the population
containing at least one large nuclear spot bearing Wlds protein (T. Wishart PhD thesis,
University of Edinburgh). Overexpression of Wlds protein either in the cerebellum or
in transfected cell lines in vitro leads to downregulation and upregulation of several
other genes. However we do not yet know any of these always required for
expression of the protective Wlf phenotype (Gillingwater et al 2006b).
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Antibody Wld-18 targets a unique 18 amino-acid peptide in the Wlds protein in
this experiment. This peptide is coded by DNA normally contained within the 5'
untranslated region of Nmnatl, expressed between the Ube4b and Nmnat portion of
the Wlcf chimeric gene. This Wld-18 antibody is both specific and versatile, hence
immunocytochemistry can be used to visualize the Wlds protein expression level.
Protein expression varied within cell types, some neurons showed intense particulate
Wld18 protein staining, while others showed very fine speckling staining (Fig 4.1). In
my study, Wlds protein expression in cerebellar granule cells showed strong punctate
expression of the mutant protein using an immunocytochemical method. All cells
were visualized by immunofluorescence using a W/^-specific primary antibody,
TRITC-conjugated secondary antibody, and topro-3 for the nuclei.
The mean intensity of rhodamine fluorescence was measured by confocal
microscopy. In homozygous Wlcf mice, Fang et al (2005) also showed that Wlds
protein is expressed in the nuclei of both neuronal and non-neuronal cells in the brain
and the spinal cord, the intensity of protein expression varied from cell to cell and the
size and shape of Wlds proteins were different, Another factor might be that more
protein expression can be observed with increasing of the laser power, for instance,
with varying laser power, the intensity and size of Wlcf dots became brighter and
larger in the young heterozygous, homozygous and old homozygous Wlcf cerebellum
preparation as visualized by confocal microscopy. In order to analyse variation in
Wlds protein expression in different types of Wlcf mice, the intensity of protein
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expression was measured at varying laser powers, namely 20%, 30%, 40%, 50%, and
60% of the maximum. The immunocytochemical data (Graph 4.7 B, C, D)
demonstrate that firstly, the intensity levels of Wlct protein expression were evidently
reduced in both young heterozygous and old homozygous Wlct mice following
increasing laser power, compared with the intensity expression in young
homozygous Wlct mice.
Regarding the influence of mouse age, this finding does not prove but is
consistent with the cause of Wallerian-like degeneration in old axotomised Wlct mice
being a reduction in protein expression level. By analysis, my immunocytochemical
suggests protein expression level was relatively higher in old Wlct mice, in
comparison to young heterozygous Wlct mice, due to a few partially occupied
endplates remaining during the degeneration process in old Wlct mice. It can hence
be postulated that this protein expression level in old Wlct mice should still prevent
some neurons from degenerating. Fang et al (2005) have shown that the intensity of
protein expression varies in different cells in the brain and spinal cord of Wlct mice.
Therefore, we can speculate that the intensity of Wlds protein expression in some
neurons is higher than in other neurons, and that these would have stronger
protection from axonal and synaptic degeneration than others. Nevertheless, these
various responses are not evident in young homozygous Wlct mice, perhaps for the
reason that the Wlct protein level is more than sufficient in these mice to prevent
axons and synapses from degeneration, whereas, following decreasing gene dose and
183
increasing mice age, these various responses become apparent, This hypothesis could
help us to explain the different degeneration states in young heterozygous and old
homozygous Wlct mice after axotomy.
However, this finding is incompatible with earlier western blotting analysis of
Wlds protein expression in brain, which suggested that expression level of the mutant
protein does not change with age (Gillingwater et al, 2002). On the other hand, the
immunostaining method is has a better spatial resolution compared to western
blotting. For instance, when performing western blotting, the whole population of
cells from the tissue sample is homogenized, proteins are extracted, run on a
denaturing gel, transferred to a blot and detected by specific antibodies. The intensity
of the detected band on a western blot therefore reflects the average expression level
of the protein in that population of cells. In immunohistochemistry, tissues are
sectioned, cells are fixed, (permeabilized) and stained in situ. The intensity of
staining (i.e. dots) indicates the expression level of that protein in particular cells.
The Wlc? gene has been sited in the region of the distal mouse chromosome 4
(Lyon, 1993), and subsequently identified to be an 85-kb tandem triplication
(Coleman, 1998). This finding led to the discovery of a chimeric gene which contains
the 5' end of Ube4b and the Nmnat (Conforti, 2000; Emanuelli et al., 2001), a key
enzyme which plays an important role in the synthetic pathway of NAD+. The third
gene, Rbp7, is a novel member of the cellular retinoid-binding protein family that is
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highly expressed in white adipose tissue and mammary glands. The protection
mechanism of the Wlct gene has not yet been delineated, although some studies have
suggested that Nmnat could play a critical role in the neuro-protective effect in
neuron in the Wlct mice.
This immunostaining finding may therefore help to explain that morphological
phenomenon of axotomised synaptic degeneration in the young heterozygous and old
homozygous Wlct mice found in the previous work, namely, the weaker synaptic
protection by Wlds protein compared to axonal protection in both young
heterozygous and old homozygous Wlcf mice following nerve section, and the
similar appearance of synaptic degeneration patterns in axotomised young
heterozygous and old homozygous Wlct mice.
Furthermore, it confirmed that Wlds protein has a strong influence in axonal
degeneration in Wlct mice. Naturally, the results of the CNS Wlds protein expression
may not provide enough evidence to explain the morphological results in the PNS,
thus, both western blotting and immonstaining on Wlds protein of spinal cord of
heterozygous and old homozygous Wlct mice would be logical next step to further
test this hypothesis in the future.
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6.5 Effect of Extrinsic Factors on Synaptic
Degeneration
6.5.1 The Effect of Length of Nerve Stump
The sciatic nerve is the largest single nerve in the mammal; it runs from each
side of the lower spine down through the posterior thigh, and all the way down to the
foot, connecting the spinal cord with the leg and foot muscles. The tibial nerve is one
of two major divisions of the sciatic nerve, supplying the hamstring muscles, the
muscles of the back of the leg, the muscles of the plantar aspect of the foot, and the
skin on the back of the leg and on the sole of the foot. The distance from the injury
sites in the sciatic and tibial nerves was almost 2cm, roughly the same distance from
the tibal nerve lesion site to the lumbrical muscles. Since the distance from the tibial
nerve to the foot is shorter than that from the sciatic nerve, synaptic degeneration
following tibial nerve section was expected to be more rapid than that following
sciatic nerve section. However, in the equivalent period following tibial nerve
axotomy, synaptic terminals degenerated slightly slower than that followed sciatic
nerve surgery. The data didn't show the significant difference between sciatic nerve
surgery and tibial nerve surgery. Previous studies suggested that increasing the
length of the distal axonal stump alters the rate of degeneration in wild-type mice
(Luco and Eyzaguime, 1955; Birks et al., 1960; Miledi and Slater, 1970). Moreover,
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Ribchester et al (1995) suggested that an increase of 1 cm in the length of the distal
stump delayed degeneration by about 1~2 days in Wlct mice.
The present data are at variance with these findings. Of note, previous studies
based their conduction on physiological measurement, whereas my study used
anatomical measurement. It is possible that the physiological integrity of axons and
synapses is more sensitive to nerve stump length than in their structural presence.
Differences in the rate of degeneration measured physiologically and anatomically
have also been reported (Ribchester et al., 1995; Gillingwater et al., 2002; 2003).
6.5.2 Dose and Injection Site
Botulinum toxin was used to test the possible role of synaptic activity in
degeneration, since this toxin blocks all neurotransmitter release (Bhidayasiri et al.,
2005; Rossetto et al., 2001). The dose and injection site of the botulinum A are
critical factors which directly affect the experiment result outcome. Since botulinum
toxin A is highly toxic, too high a dose of toxin would cause the animal to die, while
too small a dose would be ineffective in blocking synaptic transmission and hence,
preclude any effective result. Moreover, Borodic et al (1994) suggested that, the
higher the dose and volumes of BoTox Injection, the greater the penetration of the
toxin through muscle fascia, yet the lesser the spread which is reduced by
approximately 20-25% (Shaari et al., 1991). The dose used in my experiment was a
3-5pl injection containing 1-1.5 ng Botulinum Toxin Type A in mice. This range was
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sufficient to block neuromuscular transmission (see methods P146) in the injected
groups of mice (Variation in the volume and amount of BoTox injection were
required to avoid toxicity).
Likewise, to obtain a maximal effect of BoTox, the injection site is another
major determinant. In the present experiments I compared the effects of BoTox
injection into young mice and mature mice. Since the purpose of this experiment was
to test the effect of BoTox on synaptic degeneration in the NMJs of the foot, the
center of the sole seemed an ideal injection site. Stimulation of the tibial was done
before isolating the lumbrical preparation, and an absence of contractile response
was taken to indicate that the dose and route of administration were appropriate for
the present experiments.
6.5.3 BoTox Effects on Synaptic Degeneration
Following local injection into muscles, the BoTox enters the nerve terminal via
endocytosis, interacts with intracellular proteins SNAP-25 and inhibits the
neuromuscular junction. Inhibiting Ach release produces paralysis of the affected
muscles (Bhidayasiri et al., 2005; Rossetto et al., 2001).The characteristic of Wlcf
mice is slow Wallerian degeneration following the nerve injury, five days after
tibial nerve injury in Wlcf mice many endplates were still occupied, indicating
protection by the Wlcf gene was not reduced by BoTox injection. Given the
inhibiting effect of BoTox, the inactivity of synapses may well provide additional
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protective stimulus. Thesleff et al (1990) suggested that BoTox blockade delays and
prevents the retraction of synaptic terminals and motor neuron death during
development. It has also been shown that the pattern of synaptic degeneration in Wlct
mice is similar to that in neonates (Mattison et al., 1996; Parson et al., 1998;
Ribchester et al., 1999).
The results show in Fig 5.10, therefore suggest that BoTox could possibly
provide some protection against synaptic degeneration, in addition to the protective
effects of the Wlds gene, but the effect is rather slight. Since BoTox also blocks
synaptic transmission, its utility as a neuroprotective agent is likely to be minimal.
6.5.4 BoTox Effect on the Mature Wlcf Mice
In the previous chapters, I showed that synaptic terminals are slowly withdrawn
from axotomised endplates in young Wlct mice, yet this synaptic protection
phenotype is absent following axotomy in mature mice, despite the axons being still
protected from degeneration by the Wlct gene (Gilllingwater et al., 2002). In my
experiments on 7 months old Wlcf muscles, at 2 days post axotomy, most terminals
had showed fragmented and degenerative signs. In the present study, 3pl BoTox was
injected in the mice's hind feet, however, the data as presented in Figure 5.3 that this
was not sufficient to prevent rapid degeneration of synaptic terminals in mature Wlct
mice. It is hence difficult to conclude that synapses are protected strongly from
degeneration by BoTox at 3 days post axotomy, although a few endplates remain
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partial or fully occupied at this time point, Nonetheless. However, it is clear that
BoTox did not affect synaptic degeneration at 7 days post axotomy, since by this time
100% endplates had degenerated completely.
6.6 Compartmental neurodegeneration
Previous studies of the reaction of cell bodies, axons and synaptic terminals in
axotomised Wlcf mice suggests, that mechanisms of degeneration are
compartmentalised in neurons (Gillingwater and Ribchester, 2001). My current
findings, in the morphological study rather than the molecular mechanism study have
given some evidence to confirm this. For example, the time course analysis of NMJs
in these mice has shown that the rate and pattern of synaptic degeneration after
axotomy are apparently influenced by gene dose and mouse age in Wlcf mice, while
the axons are only affected slightly. Moreover, in axotomised heterozygous and old
homozygous Wlcf mice, DF and CP states were found to exist simultaneously during
the synaptic degeneration process, that is, synaptic terminals could take more than
one pathway to degenerate in young heterozygous and old homozygous Wlcf mice
after axotomy. One is similar to wallerian degeneration, and the other is a withdrawal
process similar to developmental synapse elimination in neonates. Therefore, from
the morphological study, it may be suggested that, in motor neurons, synapses have




Synaptic degeneration is the early stage of neuron degeneration in many
neurodegenerative diseases. For example, Alzheimer's disease is considered to be
mainly a kind of disease of synapses (Selkoe, 2002; Gillingwater and Ribchester,
2003). In Huntington's disease, synapse abnormalities are related with the
deterioration of motor and cognitive abilities in the central nervous system (Wishart
et al., 2006). In motor neuron disease, synapse loss is known to occur during the
early stages of Amyotrophic lateral sclerosis in the SOD1 transgenic mice model, and
the degeneration pattern of synapses is via piecemeal retraction, which is similar to
the pattern in young axotomised Wlct mice and mice neonate (Maselli et al., 1993;
Frey et al., 2000; Schaefer et al., 2002; Gillingwater and Ribchester, 2003). However,
it should perhaps be always borne in mind that synapses may be extremely
vulnerable to any malfunction, wherever it may occur in a neuron. For example, it is
otherwise healthy synapses that degenerate first after axotomy, as this thesis and
previous studies have shown. This does not mean, of course that protecting synapses
should not be the goal of treatment for neurodegenerative diseases.
Further studies of axotomy-induced synaptic degeneration in the PNS could also
provide more insight to help us understand and examine axotomy-induced synaptic
withdrawal in the CNS and the mechanisms of remodeling in central connections,
such as that in the developmental organization of the visual system and the
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cerebellum. Gillingwater et al (2006a) who studied synaptic degeneration of the CNS
in young Wlcf mice showed that the synaptic degeneration pattern is distinct from the
PNS. In the CNS, the onset of synaptic degeneration is delayed by the Wlcf gene, but
once it occurs, the form of degeneration appears similar to wild type.
A recent study showed that the Wlcf gene has a stronger protection on synaptic
degeneration in axotomy-induced transgenic rat than in Wlcf mice. Moreover, the rat
model has advantages over the mouse model for studying neurodegenerative disease
(Adalbert et al., 2005). Some of the limitations studying mouse model disease will
also be overcome in other mammalian species models (Gillingwater et al., 2006a).
The PDD analysis method is of benefit not only in Wlcf mice studies, but also for
Wlcf transgenic rats and other Wlcf transgenic mammalian species studies.
Although the mechanism by which Wlcf delays degeneration in synaptic
terminals remains unclear, the present study extends the limits of our knowledge
regarding synaptic degeneration in mutant Wlcf mice. It is known that there are
morphological and physiological similarities among naturally-occurring synapse
elimination in neonates, asynchronous withdrawal in young Wlct mice, and the
retraction pattern occurring in many forms of neuromuscular disease (Gillingwater
and Ribchester, 2003). Given the diversity of synaptic degeneration patterns in
axotomy- induced Wlcf mice under the influence of gene dose and mice age, Wlcf
mice would be a suitable target for studying the mechanism of synaptic degeneration
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in different neurodegenerative diseases. Therefore, the present findings may facilitate
us to extend the current knowledge of synaptic degeneration. Some of these provide
effective methods to study the mechanism of synaptic degeneration in Witf mice,
such as PDD analysis of NMJs and Wlds protein expression in cerebellar granule
cells. Others provide a way to delay the synaptic degeneration, such as, blocking
transmission by botulinum toxin. Thus, all data could possibly lead to useful
advances in the treatment of Alzheimeri's disease and other CNS diseases, such as
Parkinson's and Huntington's diseases, as well as PNS diseases like Amyotrophic




In this thesis, Thyl-YFP16 Wlct mice were cross-bred with Balbc/bl6 mice to
produce heterozygous Wlcf mice with fluorescently-labeled motor neurons. Synaptic
degeneration after axotomy in these mice was compared with that in Wlct
homozygous and wild-type mice. These experiments constituted a test of the
hypothesis that protection of synapses in Wlct mice depends on the "dose" of the
chimeric gene. First, analysis using PDD diagrams provided insights into the pattern
of synaptic degeneration at the axotomised NMJs of wild-type and Wlct mice. The
main states of axonal and synaptic degeneration defined for PDD analysis, namely :
DF (Disconnected/fragmented) CP (Connected partial occupancy) O (Occupied), CF
(Disconnected/fragmented), and V (Vacant), were all identified during the
degeneration process in the different types of axotomised mice. Not all patterns
occurred in all types of axotomy-induced mice. Those I observed indicated the
different trajectories taken during synaptic degeneration following axotomy in these
sets of mice. By following these trajectories we may conclude that axonal and
synaptic degeneration occur by different mechanisms in homozygous and
heterozygous Wlds mice. Protection from synaptic degeneration by the Wlds gene is
therefore much more sensitive than axon degeneration to the Wlds gene dose.
Surprisingly, my studies of Wlct gene expression in the cerebellum provided
evidence that synaptic Wlct gene expression is reduced as Wlct mice age and that
this may explain why old Wlct mice lose their synaptic protection, even in
homozygotes. This outcome may explain the findings in my morphological studies
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that axonal and synaptic degeneration patterns are similar in heterozygous Wlcf mice,
old homozygous Wlcf mice and wild-type mice.
Thirdly, since the mechanism of the Wlcf gene protecting axons and synapses
from degeneration still are not clear so far, I looked for other factors which might
also have a protective effect on nerve terminal degeneration following axotomy.
However, I was only able to confirm some of the findings of previous studies. For
example, length of the distal nerve stump did not effect synaptic degeneration in
axotomised Wlcf mice: thus, nerve terminal degeneration following tibial nerve
section was no faster than that following sciatic nerve section. In addition, although
BoTox was found to delay synaptic degeneration in young axotomised Wlcf mice,
there was no effect in old axotomised Wlcf mice. Thus, of those aspects examined,
by far the most potent effects on synaptic degeneration were Wlcf gene-dose and
age.
More experiments should be done to extend these findings. First, PDD
analysis could be applied to neonates and to some transgenic mouse models of
neurodegenerative diseases, such as the SOD1 mouse model of ALS. Such analysis
may offer a stringent test of Gillingwater & Ribchester's 'compartmental
neurodegeneration' hypothesis. Second, single cell RT-PCR western blotting and
quantitative immunostaining should be used to examine Wlds protein expression in
motor neurons of young homozygous, heterozygous and old homozygous Wlcf
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mouse spinal cord. Third, chronic stimulation of axotomised distal nerve stumps
should be tested in Wlcf mice, to find out whether the apparent lack of effect of
blocking synaptic transmission with BoTox has its counterpart when transmitter
release is instead increased after axotomy. For instances, although BoTox has only a
slight effect on synaptic protection by Wlc?, whether increasing activity has minor or
dramatic effect remain completely unknown. Together, such studies could provide to
the insights we need to find better ways of protecting synapses in devastating
diseases such as ALS, and perhaps other neurodegenerative diseases as well.
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Appendix I
Neurofilament Synaptic Vesicle and AchR
Immunocytochemistry Protocol
1. Fix in 4% Paraformaldehyde 30-45 mins
4g Paraformaldehyde
100ml 1 x Phosphate Buffered Saline
Heat to 60-70°C Whilst stirring continuously
Add 4-5 drops of 0.1 M NaOH
Wait until solution clears
Chill to 4°C in fridge
2. Wash 3 times for 10 mins in fresh lx PBS
All steps now undertaken on a platform rotator at room temperature and in a
sealed dark box to keep light out.
3. Incubate in a 0.1 M glycine solution for 1 hour
4. Incubate in a fresh 5pg/ml TRITC-a-BTX solution for 30 mins





6. Incubation in 1 antibody solution overnight:




7. Incubate for 1 hour in fresh primary solution
8. Wash 3 times for 10 mins in blocker
9. Incubate in 2 antibody solution for 4 hours
4 ml lx PBS
20pl FITC sheep-anti-mouse antibody
10. Wash 3 times for 30 mins in lx PBS
11. Mount preparation in Vectashied (Vector Laboratories Inc.) on a slide and
coverslip.
12. Store in dark box at 4 C
Fluorescence Staining for Wld3 protein
To make high Mg2+ACSF
(ACSF composition)





0.5ml 1M solution CaCl2
2.0ml 1 M solution MgCl2
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1) Fix in 4% paraformaldehyde for 20 mins
2) Wash in PBS x 2 (lOmins)
3) Incubate in blocking solution overnight in cold room on rocker.
Blocker: 4g bovine serum albumin+0.5pl Triton-X+ 100ml PBS, dissolved on
hotplace
4) Remove blocking solution and apply Primary antibodies (Wld18 ab) overnight
at 4 C:
5) Wash in PBS x 3 (10 mins) at room temperature
6) Apply secondary antibodies overnight at 4 C.
TRITC or FITC: 50pl TRITC or FITC anti-rabbit ab + 950pl PBS
7) Wash in PBS x 3 (lOmins) at room temperature
8) Apply Topro-3 (lpl topro-3 stock + 1ml PBS) for 10 mins
9) Quick wash in PBS and mount in Mowiol.
Procedure for Wlds Protein Expression Analysis
1. Load Image in order of laser power (20, 30, 40, 50, 60 etc)
2. If necessary extract red channel
3. Make Large ROI (Save as Big Selection.roi)
4. Duplicate
5. Discard original image
6. Load next Image
7. Repeat 2-6 until all images loaded
8. Make Stack
9. Make 30 x 30 pixel ROI (Save as Selection3030.roi)







16. Paste into Excel
17. Select integrated density Column
18. Paste special: Values and Transpose
19. Paste to new line
20. Back to images
21. Clear Results
22. Load Selection3030.roi (if necessary)
23. Measure Background region in each slice
24. Copy Results to Excel
25. Select Integrated density
26. Paste Special Value Transpose
27. Subtract Background from Spot at each laser power
28. Plot graph of laser power vs. corrected brightness of spot (i.e. background
subtracted spot) for each spot
29. Calculate mean (average) and Standard deviation of spot brightness for all spots
at each laser power
30. Plot graph of laser power versus mean (average) and standard deviation of spot
brightness
31. Also keep mean value from each image
32. Calculate mean spot brightness from several images and standard deviation (=










Component MW Wt Cone"
Na Ac 82.03 164.3mg 20mM
Arg. 210.7 421.4mg lOOmM
Mann. - l.Og 1%
Na S04 142.0 284.Omg lOOmM
BSA - lOO.Omg 0.1%
Dissolve above componets in distilled water.
Once dissolved adjust pH to 6.9 then pass through a 0.22|Jm millipore filter to
sterilize solution.
Split into aliquots and store in freezer.
Botulinum Toxin A- BoTox
Botulinum Toxin A from Clostridium botulinum
Supplier- Sigma Cat# B8776








***Dilute using non-sprouting buffer solution
Pipette into 30pl aliquots.
Store @ -20°C in freezer,
i.e. 6 expts @ 0.075ng/animal.
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Appendix II
Abstracts of the Neuroscience Conferences
FENS Forum 2004
For lectures, symposia and workshops, time indicates the beginning of the session.
For posters, authors are expected to be present at their posters at the time indicated.
Close window
First author: Fan, Li (poster)
Poster 42 - Mon 12/07, 16:00 - Hall I
Session 109 - Synaptogenesis II
Abstract A109.6, published in FENS Forum Abstracts, vol. 2, 2004.
Ref.: FENS Abstr., vol.2, A109.6, 2004
Author(s) Fan L., Gillingwater T. H., Thomson D., Thomson A. & Ribchester
R. R.
Addresse(s) Divison of Neuroscience, University of Edinburgh, Edinburgh, EFI8 9JZ, UK
Title Neuroprotective phenotype at neuromuscular junctions in homozygous and
heterozygous WldS mutant mice.
Text In WldS mutant mice axonal (Wallerian) degeneration is delayed 10-fold
after axotomy in homozygotes, resulting from expression of the chimeric
gene Wld (1). Synapses are less well protected and retract from endplates
after axotomy. With age, protection of neuromuscular synapses by the Wld
gene is lost completely. Here we examined the extent of synaptic protection
in heterozygous WldS mice. To generate heterozygotes, we cross-bred
BalbC mice with homozygous ThylYFP/Wlds mice, that also express
fluorescent protein in motoneurones. We compared synaptic and axonal
preservation 3-4 days after axotomy with homozygous Wlds and wild-type
thylYFP mice. Sciatic nerve lesions were performed under N20/halothane
anaesthesia. 1-4 days later, mice were killed and both tibial nerves
removed. Lumbrical muscles were also removed and postsynaptic
acetylcholine receptors were labelled with TRITC-a-BTX. In wild-type mice,
most axons had degenerated within 1-2 days. In heterozygous Wlds mice,
axonal preservation in the lesioned tibial nerve was similar to that observed
in homozygotes. However, virtually all (>95%) axotomised intramuscular
axon branches and motor nerve terminals at neuromuscular junctions in
heterozygous WldS mice had degenerated, as in wild-type mice. This was
distinct from both young (1-2 month old) homozygous WldS muscles, where
90-100% of nerve terminals persisted at 3 days post axotomy, and older
WldS mice (>7 months) where synapses were lost but preterminal axons
remained. The data support a compartmental model of
neurodegeneration(2) and suggest that moderate levels of Wld protein
expression are not sufficient to protect synapses from the effects of
axotomy. Regulation of other factors will be required to fully protect
synapses from degeneration or elimination.
1. Mack, T. G. A. et al. (2001). Nat Neurosci 4:1199-1206
2. Gillingwater et al (2002) J. Physiol. 543.3.
Theme Development
Synaptogenesis and activity-dependent development / Synapse formation:
PNS
222
Program Number: 670.16 Day / Time: Tuesday, Nov. 15, 11:00 AM - 12:00 PM
Rapid degeneration of motor nerve terminals in heterozygous WldS
mice
L.Fan; T.H.Cillingwater; J.E.Haley; D.Thomson; A.Thomson; R.R.Ribchester SPON: British
Neurosci. Assoc.
Centre for Neuroscience Research, Univ. of Edinburgh, Edinburgh, United Kingdom
WldS mutant mice express a chimeric gene that delays Wallerian degeneration by about a
factor of ten. Synapses are less well protected and with age, protection of neuromuscular
junctions is lost completely (Gillingwater et al., 2002, J Physiol. 543, 739-755). Here we
focused on neuromuscular synaptic protection in heterozygous WldS mice. We mated
ThylYFP16/WldS homozygous mice with BalbC mice. Sciatic nerve lesions were performed in
F1 heterozygotes under N20/halothane anaesthesia. Mice were killed and lumbrical
muscles with attached nerves were removed 6-240h later. ACh receptors were labelled with
TRITC-0f-BTX. Axonal preservation in these WldS/+ mice(ca. 100%) was indistinguishable
from WldS homozygotes for at least 72 hours. But virtually all motor nerve terminals became
fragmented and disconnected from their parent axons in WldS/+ mice within 24 hours, as in
wild-type mice. At 17 hrs, 80.68—3.66% (S.E.M., n=3 mice) of terminals in WldS/+ mice had
degenerated in this fashion, compared with 88.11—4.72% (n = 3) at 14.5 hours in +/+ mice.
The rapid synaptic degeneration in heterozygotes contrasted with more gradual and
asynchronous synaptic retraction in young adult WldS/WldS mice. At 5 days, 80.76—2.12%
(n=4 muscles) of motor nerve terminals in WldS/WldS mice were still connected to their
parent axon terminals although 58.82 — 3.67% of these only partially occupied motor
endplates. Older WldS/WldS mice (> 7 months of age) showed rapid synaptic degeneration,
as in young WldS/+ mice. Immunostaining showed similar numbers of neurones strongly
expressing WldS protein, but the intensity of staining in WldS/WldS was about twice that in
WldS/+ mice. The expression levels did not decline with age. The data confirm that synaptic
protection is sensitive to WldS gene dose but high levels of WldS protein expression are
insufficient to preserve neuromuscular synapses in mature mice. Attempts to transfer
WldS-induced neuroprotection to neurological mutants should take account of these factors.
Support Contributed By: MRC, Wellcome Trust,BNA
Citation: L.Fan, T.H.Gillingwater, J.E.Haley, D.Thomson, A.Thomson, R.R.Ribchester. Rapid
degeneration of motor nerve terminals in heterozygous WldS mice. Program No. 670.16.
2005 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience
2005 Copyright by the Society for Neuroscience all rights reserved. Permission to republish
any abstract or part of an abstract in any form must be obtained in writing from the SfN
Office prior to publication
Application Design and Programming Copyright ScholarOne, Inc. All Rights Reserved. Patent
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